Restoring Digestive Health by Corbin, DNP, APRN, FNP-C, Kristin M
Georgia College 
Knowledge Box 
Doctor of Nursing Practice (DNP) Translational 
and Clinical Research Projects School of Nursing 
Fall 12-8-2015 
Restoring Digestive Health 
Kristin M. Corbin, DNP, APRN, FNP-C 
Georgia College and State University, kristin.corbin@bobcats.gcsu.edu 
Follow this and additional works at: https://kb.gcsu.edu/dnp 
 Part of the Alternative and Complementary Medicine Commons, Digestive, Oral, and Skin Physiology 
Commons, Digestive System Diseases Commons, and the Family Practice Nursing Commons 
Recommended Citation 
Corbin, DNP, APRN, FNP-C, Kristin M., "Restoring Digestive Health" (2015). Doctor of Nursing Practice 
(DNP) Translational and Clinical Research Projects. 12. 
https://kb.gcsu.edu/dnp/12 
This Dissertation is brought to you for free and open access by the School of Nursing at Knowledge Box. It has 
been accepted for inclusion in Doctor of Nursing Practice (DNP) Translational and Clinical Research Projects by an 
authorized administrator of Knowledge Box. 






Restoring Digestive Health with Probiotics, Digestive Enzymes, and Glutamine  
Kristin M Corbin, DNP, APRN, FNP-C 


















Dr. Tasneem Bhatia, MD 




RESTORING DIGESTIVE HEALTH  2 
TABLE OF CONTENTS 
           Page 
Abstract……………………………………………………………………………………………7 
List of Tables……………………………………………………………………………………...9 
List of Figure……………………………………………………………………………………..10 
Chapter                          Page 
I. INTRODUCTION…………………………………………………………………...11 




Brain Gut Communication……………………………………………………….14 
Genetic Factors…………………………………………………………….…….14 
Infection and Intestinal Inflammation……………………………………………15 
Altered Gut Bacteria…………………………………………………..…………16 
Costs………………………………………………………………………………….16 
Symptoms and Treatment……………………………………………………….…...17 
Purpose and Clinical Questions……………………………………………………...17 
Pre-Intervention Clinical Questions………………………………………………….19 
Post-Intervention Clinical Questions………………………………………...………19 
Challenges…………………………………………………………………………....20 
II. REVIEW OF LITERATURE………………………………………………………..21 
Probiotics………………………………………………………………………...…..21 






Weight and Waist Circumference……………………………………………………32 
Quality of Life………………………………………………………………………..33 
Stress…………………………………………………………………………………34 
Duration of Symptoms……………………………………………………………….34 
Number of Attempted Treatments…………………………………………………...35 
Theoretical Framework………………………………………………………………36  
III. PROJECT DESIGN AND METHODOLOGY……………………………………...41 
Objectives…………………………………………………………………………....41 








Gastrointestinal Quality of Life Index…………………………………………...47 
Perceived Stress Scale……………………………………………………………50 





Intervention Questions…………………………………………………………...56  
Dissemination………………………………………………………………………..56  
Data Analysis………………………………………………………………………...57 
Analysis Plan for Research Questions………………………………………………57 
IV. RESULTS……………………………………………………………………………62 
Data………………………………………………………………………………..…62 
Pre-Intervention Sample Characteristics……………………………………………..64 
Description of Research Instruments………………………………………………...65 
Waist Circumference…………………………………………………………….66 
Weight……………………………………………………………………………67 
Perceived Stress Scale……………………………………………………………67 
Gastrointestinal Quality of Life Index…………………………………………...67 
Pre-Intervention Clinical Research Questions……………………………………….68  
Results for Research Question 1…………………………………………………68 
Results for Research Question 2………………………………………………....70 
Results for Research Question 3…………………………………………………71 
Results for Research Question 4…………………………………………………73 
Results for Research Question 5………………………………………………....74 
Results for Research Question 6…………………………………………………74 
RESTORING DIGESTIVE HEALTH  5 
 Post-Intervention Data…………………………………………………………………...75 
Sample Characteristics…………………………………………………………………...75 
 Self-Reported Gastrointestinal Symptoms…………………………………………….…78 
 Post- Intervention Description of Research……………………………………..……….79  
  Perceived Stress Scale……………………………………………………………80 
  Gastrointestinal Quality of Life Index………………………………………..….80  
  Weight and Waist Circumference……………………………………………..…81  
Post-Intervention Clinical Questions………………………………………………….…81 
Results for Research Question 7…………………………………………………81 
Results for Research Question 8…………………………………………………83 
Results for Research Question 9…………………………………………………84 
Results for Research Question 10………………………………………………..84 







Duration of Symptoms…………………………………………………………...92 
Number of Attempted Treatments……………………………………………….93 
Additional Comments……………………………………………………………95 
Instruments………………………………………………………………………..….99 
RESTORING DIGESTIVE HEALTH  6 
Weight and Waist Circumference……………………………………………..…99 
Perceived Stress Scale………………………………………………………..…101 
Gastrointestinal Quality of Life Index……………………………………...…..101 
Strengths of the Study……………………………………………………………....102 
Limitation of the Study……………………………………………………………..103 
Implications for Practice……………………………………………………………104 






Appendix A: Flow Diagram for Research Study…………………………………...124 
Appendix B: Example of Recruiting Flyer…………………………………………125 
Appendix C: Informed Consent………………………………………………….…127 








RESTORING DIGESTIVE HEALTH  7 
Abstract 
Purpose: The purpose of this translational research project was to outline the healthcare 
problems associated with Functional Gastrointestinal Disorders and to explore the effectiveness 
of a gastrointestinal protocol utilized at Atlanta Center for Holistic and Integrative Medicine. The 
goal of this protocol is to restore digestive health with probiotics, digestive enzymes, and 
glutamine. 
Background: Functional Gastrointestinal Disorders affect one in every four adults in the United 
States. These disorders encompass a variety of symptoms including diarrhea, constipation, 
cramping, abdominal pain, flatulence, reflux, and bloating without an identified physiological 
cause. There is currently no cure for Functional Gastrointestinal Disorders and treatment focuses 
on symptom management. The majority of those suffering from Functional Gastrointestinal 
Disorders are unsatisfied with their current treatment regimen leading to physical, social, and 
emotional distress.  
Method: This prospective cohort study examined 98 adult participants with Functional 
Gastrointestinal Disorders. Each participant was instructed to take probiotics, digestive enzymes, 
and glutamine daily for 8-weeks. The participants were evaluated by a virtual survey at baseline, 
weekly, and after 8-weeks of intervention. The pre and post-intervention surveys included age, 
gender, ethnicity, duration of symptoms, number of attempted treatments, weight, waist 
circumference, the Perceived Stress Scale, and the Gastrointestinal Quality of Life Index.  
Results: A total of 86 participants completed the entire 8-week intervention. Based on the results 
of this study, there were three statistically significant predictors of lower gastrointestinal quality 
of life based on the Gastrointestinal Quality of Life. These three predictors include (1) 
minorities, (2) higher levels of stress based on the Perceived Stress Scale, and (3) greater than 3 
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attempted treatments. After the 8-week intervention, the participants had significant weight loss 
and improved gastrointestinal quality of life scores.  
Discussion: This research study is the first to examine the combined benefits of probiotics, 
digestive enzymes, and glutamine. In this study, participants had significant improvements in 
weight loss and gastrointestinal quality of life indicating that this protocol can be an effective 
regimen for treating patients with Functional Gastrointestinal Disorders.  
 
 
KEY WORDS:  Functional Gastrointestinal Disorders, Perceived Stress, Gastrointestinal 
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Restoring Digestive Health with Probiotics, Digestive Enzymes, and Glutamine 
CHAPTER I 
Introduction 
Gastrointestinal disorders are highly prevalent in the United States. The majority of 
gastrointestinal symptoms reported to healthcare providers are functional disorders rather than 
disease states (Stake-Nilsson, Hultcrantz, Unge, & Wengström, 2012). Disease states are 
associated with a specific underlying pathology that can be identified through diagnostic testing, 
while functional disorders have an unknown structural or physiological abnormality (Stake-
Nilsson et al., 2012). The term used to identify this syndrome is Functional Gastrointestinal 
Disorders. This population often experiences little to no improvement in their symptoms, leading 
to physical, mental, and social distress (Markert, Suarez-Hitz, Ehlert, & Nater, 2014; Spiegel et 
al., 2011; Stake-Nilsson et al., 2012).  
Understanding Functional Gastrointestinal Disorders 
Definition 
The term Functional Gastrointestinal Disorders is used when the body’s digestive tract 
seems to be functioning normally, yet it causes significant gastrointestinal symptoms in an 
individual’s quality of life. Examples of this in the gastrointestinal system are changes in the 
motility of the intestines, sensitivity of the nerves in the intestines, or the way in which the brain 
controls the functions of the digestive tract (International Foundation of Functional 
Gastrointestinal Disorders [IFFGD], 2015). Despite the impaired function, healthcare providers 
are unable to identify a structural abnormality through diagnostic testing, such as endoscopy, 
colonoscopy, CT scan, x-ray, or blood tests (IFFGD, 2015). In other words, Functional 
Gastrointestinal Disorders are defined as chronic or recurrent gastrointestinal symptoms, such as 
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pain, heartburn, abdominal distention, nausea, vomiting, bloating, constipation, or diarrhea, 
without a known structural or biochemical abnormality (Markert et al., 2014). 
Prevalence 
Functional Gastrointestinal Disorders are the most common gastrointestinal disorder seen 
in the general public, affecting one in every four people in the United States (IFFGD, 2015). 
Some of the most common Functional Gastrointestinal Disorders include functional dyspepsia, 
irritable bowel syndrome, and functional constipation. Functional dyspepsia affects 20-30% of 
the general population followed by functional constipation (up to 27%) and irritable bowel 
syndrome (10-20%) (IFFGD, 2009). These disorders make up 41% of all gastrointestinal 
symptoms reported to healthcare providers and therapists (IFFGD, 2015). Functional 
Gastrointestinal Disorders seem to affect females more frequently than males, yet the etiology 
behind this remains unknown (Markert et al., 2014).  
Functional Dyspepsia is defined as symptoms that originate from the upper digestive 
system including the stomach and small intestines without any structural or metabolic diseases 
known (IFFGD, 2015). This disorder is estimated to affect 30% of the general population 
(IFFGD, 2015). Symptoms of dyspepsia vary tremendously including burning, pressure, fullness, 
nausea, early satiety, belching, and bloating. This disorder is often chronic with approximately 
50% of patients having symptoms of functional dyspepsia for over 5-years (IFFGD, 2015). 
Two of the most common digestive disorders include irritable bowel syndrome and 
inflammatory bowel disease. These two disorders affect 16.3 million people in the United States 
alone (McCormick et al., 2012). Irritable bowel syndrome patients account for 3.65 million 
outpatient provider visits annually (IFFGD, 2009). Unlike irritable bowel syndrome, 
inflammatory bowel disease is a true disease state that encompasses both Ulcerative Colitis and 
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Crohn’s Disease. With this diagnosis, there is clear evidence to support the etiology of 
inflammation within the digestive tract. In contrast, irritable bowel syndrome is classified as a 
Functional Gastrointestinal Disorder because there is no structural abnormality associated with 
the disorder and the etiology remains vague and inconclusive. Functional constipation is defined 
as difficult, infrequent, and often incomplete defecation without a known cause (IFFGD, 2015).  
Etiology 
 Despite increasing research, the pathophysiology behind Functional Gastrointestinal 
Disorders remains ambiguous and treatment options are limited (Markert et al., 2014). Current 
evidence suggests that the etiology behind Functional Gastrointestinal Disorders is 
biopsychosocial in nature (Markert et al., 2014). Over the past two decades, specific 
organizations, such as the International Foundation of Functional Gastrointestinal Disorders 
(IFFGD) have discovered some possible mechanisms behind the development of Functional 
Gastrointestinal Disorders (IFFGD, 2009). These discoveries have found abnormalities in the 
brain-gut communication, genetic factors, infection, altered gut bacteria, and intestinal 
inflammation (IFFGD, 2009). Two thirds of these patients are thought to have an increased 
sensitivity to gut stimuli or “visceral hypersensitivity”; others suffer from abnormal motility that 
can cause a wide range of symptoms including swallowing difficulties, heartburn, diarrhea, 
constipation, and incontinence (IFFGD, 2009). Other researchers are questioning the association 
between medication use and Functional Gastrointestinal Disorders. A population-based study 
was conducted to determine whether proton pump inhibitors (PPI), antidepressants, and/or 
narcotics were contributing to the high prevalence of Functional Gastrointestinal Disorders 
(Choung, Locke, Schleck, Zinsmeister, & Talley, 2013). The results found that PPI use was 
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causing significant irritable bowel syndrome and dyspepsia symptoms, while antidepressant use 
was significantly associated with bloating (Choung et al., 2013). 
Brain-Gut Communication. Research concerning the brain-gut connection is 
continually evolving. External and internal stressors may have an effect on gastrointestinal 
motility and sensation. For example, some individuals may experience the sensation of 
butterflies in their stomach when anxious or an upset stomach related to other emotions, such as 
sadness (IFFGD, 2009). Pain is often a subjective symptom associated with Functional 
Gastrointestinal Disorders. When assessing pain, it is important to evaluate how the brain is 
responding to the signal. Patients diagnosed with irritable bowel syndrome were shown to have 
more brain activation in the area responsible for afferent processing and emotional arousal 
compared to the control group (Tillisch & Labus, 2011). Structurally, the amount of gray matter 
an individual has may be a factor in chronic illnesses. For example, individuals suffering from a 
variety of illnesses including chronic pain, depression, and irritable bowel syndrome have been 
shown to have varying amounts of gray matter (Tillisch & Labus, 2011). Specifically, irritable 
bowel syndrome was associated with decreased gray matter density in several areas of the brain 
(Tillisch & Labus, 2011). 
Genetic Factors. Functional Gastrointestinal Disorders have been shown to run in 
families (IFFGD, 2009). Research is beginning to identify genes that may predispose individuals 
to Functional Gastrointestinal Disorders. For example, the beta-2 adrenergic receptor (ADRB2) 
is an essential target for epinephrine, which is a pain signaling neurotransmitter. Evidence has 
found ADRB2 minor alleles at rs1042714 to be a predictor for Functional Gastrointestinal 
Disorders and may influence bowel symptom severity and quality of life (Kushnir et al., 2013). 
Another polymorphism examined is the Serotonin Transporter (SERT) role in irritable bowel 
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syndrome. In patients with irritable bowel syndrome, this gene has been shown to play a key role 
in motility-related symptoms (Wang et al., 2012). 
Infection and Intestinal Inflammation. Individuals that suffer from a gastrointestinal 
infection have a higher risk of developing irritable bowel syndrome symptoms that can persist 
for months to years (IFFGD, 2009). It is hypothesized that these symptoms may be the result of 
persistent, low-grade inflammation (IFFGD, 2009). Current research supports that individuals 
suffering from functional dyspepsia and irritable bowel syndrome have a higher risk of 
developing bouts of infectious gastroenteritis (Simrén et al., 2013). Porter et al. (2011) conducted 
a study on 31,866 U.S Military personnel diagnosed with Functional Gastrointestinal Disorders 
to examine the association between Functional Gastrointestinal Disorders and infectious 
gastroenteritis. The results of this study showed a significant association between Functional 
Gastrointestinal Disorders and infectious gastroenteritis (p< 0.001) (Porter et al., 2011). The 
distribution is as follows: specific bacterial pathogen (1.2%), bacterial without a specific 
pathogen identified (38.9%), protozoal (0.7%), and viral (61.9%) (Porter et al., 2011).  
In the United Kingdom, a large study was conducted to assess the association of 
autoimmune disease and Functional Gastrointestinal Disorders (Ford, Talley, Walker, & Jones, 
2014). This study examined the prevalence of autoimmune disorders among 23,471 patients with 
Functional Gastrointestinal Disorders including functional diarrhea, chronic idiopathic 
constipation, or multiple Functional Gastrointestinal Disorders. The results of this study found 
that those suffering from rheumatologic autoimmune disorders had a significantly higher 
incidence of Functional Gastrointestinal Disorders including functional diarrhea, chronic 
idiopathic constipation, and multiple Functional Gastrointestinal Disorders (Ford, Talley, et al., 
2014).  
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Altered Gut Bacteria. One of the most recent hypotheses for Functional Gastrointestinal 
Disorders is that an abnormal intestinal microflora can activate mucosal innate immune system 
responses that increase the epithelial permeability, activate nociceptive sensory pathways, and 
dysregulate the enteric nervous system (Simrén et al., 2013). In the human digestive tract, there 
are more than 500 different species with an immense variety of aerobic and anaerobic bacteria 
(Ringel & Ringel-Kulka, 2011). Some of these bacteria are known to be beneficial to a person’s 
health by helping to maintain a normal functioning intestine; while other bacteria can cause 
infection, or inflammation. When the normal balance in the intestine between beneficial and 
harmful bacteria is changed, it may lead to changes in the function of the gastrointestinal tract 
and cause chronic gastrointestinal symptoms (IFFGD, 2009).  
Costs 
In the United States, gastrointestinal disorders are the leading cause of outpatient office 
visits (Myer et al., 2013). Unfortunately the only data available was from 2004, which indicated 
72 million outpatient office visits in the United States were associated with a gastrointestinal 
diagnosis (Myer et al., 2013). Women had a 20% higher rate of ambulatory visits than men, with 
no differences observed between Caucasians and African Americans (Myer et al., 2013). It is 
estimated that Functional Gastrointestinal Disorders are costing our society over $30 billion 
annually (IFFGD, 2009). Direct costs associated with irritable bowel syndrome alone are 
estimated at $1.5 billion annually and as high as $10 billion in adjusted costs, excluding 
prescriptions and over the counter medications (IFFGD, 2009). It is estimated that indirect costs 
associated with irritable bowel syndrome may be as high as $20 billion annually from decreased 
work productivity (IFFGD, 2009).    
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Healthcare costs related to gastrointestinal disorders expand beyond outpatient care. In 
2007, there were 15.1 million emergency room visits associated with gastrointestinal symptoms 
(Myer et al., 2013). The total annual charges for all Emergency Department visits with a primary 
gastrointestinal diagnosis was $27.9 billion with each visit averaging $2,354 (Myer et al., 2013). 
Symptoms and Treatment  
 The symptoms associated with Functional Gastrointestinal Disorders vary greatly and in 
some cases the symptoms overlap. Common symptoms include abdominal pain, bloating, 
heartburn, nausea, constipation, diarrhea, bloating, urgency, decreased appetite, swallowing 
difficulties, and incontinence (IFFGD, 2009). Unfortunately, there is no cure for Functional 
Gastrointestinal Disorders; rather treatment focuses on symptom management and improvements 
in patients’ overall quality of life. Current treatment modalities include antidepressants to 
decrease intestinal hypersensitivity, relaxation techniques, avoiding known food triggers, 
medications to regulate bowel function, biofeedback therapy, hypnosis, and cognitive behavior 
therapy to help restore a sense of control over the disorder (IFFGD, 2009). Even these treatments 
have limited efficacy and have potential adverse effects (Hungin et al., 2013). Further research is 
needed for a safe and effective long-term treatment for Functional Gastrointestinal Disorders 
symptoms (Waller et al., 2011). 
Purpose and Clinical Question 
Maintaining a normally functioning gastrointestinal tract is essential for health. The 
gastrointestinal tract is a large organ in the human body encompassing everything from the 
mouth to the anus. The intestinal mucosa is the body’s primary line of defense against toxins and 
bacteria (Resnick, 2010). Mucosal damage and intestinal inflammation can progress to chronic 
disease, autoimmune responses, and systemic inflammation (Resnick, 2010).  Several conditions 
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are associated with intestinal permeability defects including multiple organ failure, chronic 
fatigue syndrome, ulcerative colitis, Crohn’s disease, celiac disease, irritable bowel syndrome, 
juvenile onset arthritis, food allergies, chronic heart failure, and psychological conditions, such 
as depression and anxiety (Resnick, 2010). Long-term gastrointestinal reflux disease increases 
the risk of esophageal strictures, esophageal ulcers, or precancerous cells, as seen in Barrett’s 
esophagus (Mayo Clinic, n.d.).  Chronic diarrhea is associated with malabsorption; this can cause 
complications including electrolyte imbalances, dehydration, vitamin deficiencies, diminished 
urine output, kidney failure, and orthostatic hypotension (Marks, 2014). 
The specific aim of this project was to outline the healthcare problems associated with 
functional gastrointestinal disorders and to explore the effectiveness of a gastrointestinal protocol 
implemented at Atlanta Center for Holistic and Integrative Medicine (ACHIM). This protocol 
was designed to help restore digestive health. Conventional medications play a key role in 
improving gastrointestinal disorders outcomes; such as proton pump inhibitors and antibiotics for 
the treatment of H pylori. However, all medications come with potential adverse effects. For 
example, long term use of proton pump inhibitors is associated with pneumonia, fractures, 
vitamin B12 deficiencies, hypomagnesaemia, and pneumonia (Owen, Marks, & Banks, 2014). 
The goal of ACHIM’s gastrointestinal protocol was to naturally heal and restore a normal 
functioning digestive system with minimal to no adverse effects. The purpose of this project was 
to determine if adult patients with functional gastrointestinal disorders report improved 
abdominal symptoms based on the Gastrointestinal Quality of Life Index after eight weeks of 
probiotics, digestive enzymes, and glutamine.  This translational project was designed to 
quantify the benefits associated with this well-established protocol. A thorough literature review 
and synthesis of evidence related to probiotics, digestive enzymes, and glutamine was conducted 
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and the pertinent results are disseminated throughout this paper. The paper concludes with a 
thorough discussion of the research findings. Below is a list of the clinical research questions. 
Pre-Intervention Clinical Questions 
1. What demographic factors (age, gender, ethnicity, duration of symptoms, and number of 
attempted treatments) are associated with a lower level of gastrointestinal quality of life? 
2. What is the association between patients’ perceived stress and gastrointestinal quality of 
life? 
3. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) what is the association of perceived stress on 
gastrointestinal quality of life?  
4. What demographic factors (age, gender, ethnicity, duration of symptoms and number of 
attempted treatments) are associated with an increased weight and weight circumference? 
5. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments), what is the association between perceived stress and 
waist circumference and weight?  
6. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments), is there an association between gastrointestinal quality 
of life and weight and waist circumference?  
Post-Intervention Clinical Questions  
7. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there an 
association between patients' perceived stress and gastrointestinal quality of life? 
8. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
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enzymes, and glutamine, what is the association of perceived stress on gastrointestinal 
quality of life?  
9. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
enzymes, and glutamine, what is the association between perceived stress and waist 
circumference and weight?  
10. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
enzymes, and glutamine, what is the association between gastrointestinal quality of life 
and weight and waist circumference?  
11. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there a 
statistically significant change in the gastrointestinal quality of life, weight, waist 
circumference, and perceived stress? 
Challenges 
  Integrative Medicine utilizes both conventional and alternative medicine modalities to 
improve the patient’s overall healthcare outcomes. Since integrative medicine incorporates non-
mainstream therapies, the scientific evidence is limited, making elements of the literature review 
challenging. Restoring digestive health is a multi-factorial concept. Several factors play a role in 
restoring digestive health including stress reduction, brain-gut connection, and ruling out any 
food intolerances and allergies. This study did not alter participants’ diet or lifestyle. It primarily 
examined the benefits of probiotics, digestive enzymes, and glutamine on restoring digestive 
health.  
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CHAPTER II 
Review of Literature 
 Recently, research has gained interest in the importance of gut-related health problems, 
such as the increasing evidence that a poor digestive tract is associated with autoimmune 
diseases and inflammatory processes (Ritchie & Romanuk, 2012). The restoring digestive health 
protocol utilized at the Atlanta Center for Holistic and Integrative Medicine is unique to the 
practice. Consequently, there is not any research to support the combination of probiotics, 
digestive enzymes, and glutamine on digestive health. Therefore, a comprehensive literature 
review was conducted to assess the effectiveness of probiotics, digestive enzymes, and glutamine 
individually. A separate literature review was conducted to find a valid and reliable instrument 
that measures gastrointestinal symptoms. Each literature review was conducted primarily 
through GALILEO and Google Scholar. All articles included in this literature review were peer-
reviewed, scholarly articles.  
Probiotics 
The large amount of bacteria in the digestive tract is known as the intestinal microflora. 
In the human digestive tract, it is estimated that the intestinal microflora contains 1014 cells, 
which is thought to be ten times more than the number of cells in the entire human body (Simrén 
et al., 2013). The intestinal microflora has been researched heavily in recent years for its 
potential influence on gastrointestinal symptoms and diseases. Some of these organisms have 
been shown to be beneficial to one’s health, while others may cause infection or inflammation 
(IFFGD, 2009). When the normal balance in the intestines between beneficial and harmful 
bacteria changes, it may lead to negative results in the function of the gastrointestinal tract 
(IFFGD, 2009).  
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The beneficial bacteria for the digestive tract are known as probiotics. The term probiotic 
is derived from the Latin words “pro” and “bios” meaning “for life” (Castellazzi et al., 2013). Eli 
Metchnikoff first coined the term probiotic in 1907 (Castellazzi et al., 2013). He was the first 
man to propose the notion that consuming live microorganisms may have potentially beneficial 
effects on human’s overall health (Castellazzi et al., 2013). Probiotics can be supplemented or 
naturally found in foods, such as yogurt, kefir, miso, tempeh, and teas like Kombucha. Basically, 
probiotics are live microorganisms that help maintain and restore beneficial intestinal microflora 
that have the ability to prevent or treat gastrointestinal disorders and other related systemic 
conditions (Resnick, 2010). Restoring the normal flora in the digestive tract is crucial for 
digestive health, because probiotics can act as an intestinal barrier to pathogen causing 
microorganisms (Rao & Samak, 2013).  
In the United States, there has been an overall improvement in hygiene and nutrition that 
has resulted in a significant reduction in overall bacteria exposure, including beneficial bacteria 
(Ritchie & Romanuk, 2012). Through experimentation, it is known that gut microflora is 
essential to the normal development of the immune system, growth and development (Hickson, 
2013). Probiotics have been shown to be beneficial for cytoprotection, cell proliferation, cell 
migration, resistance to apoptosis, and synthesis of proteins and gene expression (Rao & Samak, 
2013). The beneficial properties of probiotics include protective barriers, enhancing immune 
responses, and clearing pathogens in the gastrointestinal tract (Ritchie & Romanuk, 2012).  
One study found that supplementing probiotics significantly helped treat inflammatory 
bowel disease (Cary & Boullata, 2010). Other symptom improvements seen with probiotics 
include a reduction in abdominal pain and bloating (Jafari, Vahedi, Merat, Momtahen, & Riahi, 
2014; Rogha, Esfahani, & Zargarzadeh, 2014). Probiotics have the ability to significantly 
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improve whole gut transit time by up to 12.4 hours, improve stool consistency, and increase stool 
frequency by 1.3 bowel movements per week in patients with constipation (Dimidi, 
Christodoulides, Fragkos, Scott, & Whelan, 2014). 
Probiotics can be bacteria or yeast. The most common bacterial probiotics include 
Lactobacillus and Bifidobacterium groups. These include a number of different strains including 
L. rhamonusus, L. bulgaricus, L. salivarius, L. plantarum, L. casei, B. infantis, and B. longum.  
The most common beneficial yeast is Saccharomyces boulardii. In order for probiotics to be 
effective, they must be able to adhere to the gut epithelium cells, eliminate or reduce pathogenic 
adherence, produce and multiply acids, such as, hydrogen peroxide, which will ultimately protect 
the digestive tract against pathogen growth (Castellazzi et al., 2013). 
Research on the benefit of probiotic supplementation is often strain specific (Waller et 
al., 2011). For example, L. rhamnosus GG is a specific strain that has been shown to be 
beneficial in antibiotic-associated diarrhea (Hickson, 2013; McFarland, 2008; Suardi, Crippa, & 
Monforte, 2013). This is important because in the United States, it is estimated that 258 million 
course of antibiotics were prescribed in 2010; that is 833 antibiotic prescriptions per 1,000 
people (Hickson, 2013). The incidence of antibiotic associated diarrhea is estimated to affect up 
to 30% of adults prescribed antibiotics (McFarland, 2008). Probiotics can be recommended 
prophylactically to prevent antibiotic associated diarrhea. Individuals that supplement probiotics 
containing S. boulardii while taking an antibiotic have half the risk of getting antibiotic 
associated diarrhea compared to those not taking this yeast (Hickson, 2013). 
Bifidobacterium lactic HN019 is a probiotic strain for which many health benefits have 
been established, primarily related to immune enhancement (Waller et al., 2011). Dietary 
consumption of the probiotic B. lactis HN019 is well tolerated, decreases whole gut transit time 
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in a dose-dependent manner, and reduces the frequency of functional gastrointestinal symptoms 
in adults (Waller et al., 2011). 
According to the Natural Medicines database, the level of evidence associated with 
probiotics is a grade A (strong scientific evidence) for acute diarrhea and atopic dermatitis and a 
grade B (good scientific evidence) for cirrhosis, dental caries, growth, immune enhancement, 
irritable bowel syndrome, sinusitis, and ulcerative colitis (Natural Standards, 2015c). Natural 
Medicines is an international research database that maintains up to date, comprehensive 
systematic reviews on complementary and alternative medicine. It adheres to the most recent 
recommendations of the Institute of Medicine for all systematic reviews and clinical practice 
guidelines. The editorial board performs multiple rounds of blinded multidisciplinary peer 
review methodologies to ensure the accuracy of the information.  
Probiotics have been shown to be safe with minimal adverse effects. Consumers can 
easily find probiotics in natural food sources, such as kefir, yogurt, or Kombucha. Probiotics can 
also be found in the form of a supplement over the counter at grocery stores or health food 
stores. A meta-analysis of 28 randomized controlled studies found probiotics to be safe with no 
adverse effects reported in any of the 28 studies (Hungin et al., 2013). Probiotics are not 
metabolized through the CYP 450 system; therefore they do not interact with other medications 
that are metabolized through the CYP 450 system. The therapeutic dose of probiotics is 
important, however the ideal recommended dose remains unclear (Hickson, 2013). There are 
currently no clinical guidelines for the recommendation of probiotics in the outpatient setting. 
Although there is an abundant amount of evidence to support probiotics, the specific strains, 
dose, and duration vary depending on the study conducted. Therefore, future research is needed 
to assess what strains, specific doses, and duration are the most beneficial. At Atlanta Center for 
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Holistic and Integrative Medicine the protocol for restoring digestive utilizes multi-strain 
probiotics with at least 20 billion CFUs.  
Glutamine 
 Glutamine is a functional amino acid that has several beneficial properties in the 
digestive tract (Wang et al., 2014). In healthy individuals, glutamine is the most abundant amino 
acid in muscles and plasma; however, after injuries, surgeries, or infection, glutamine 
concentration significantly decreases (Mochiki et al., 2011). Glutamine is naturally found in 
several foods including grass-fed beef, bison, chicken, eggs, whey protein, and certain cheeses. 
Health food stores sell glutamine over the counter as a supplement in the form of a capsule or 
powder. Glutamine is often added to protein powders or other nutritional shakes. L-glutamine 
has been shown to help maintain the intestinal barrier function and help fight off foreign 
microorganisms including bacteria, viruses, and funguses (Resnick, 2010). In recent years, 
glutamine has been researched for its role in gut mucosal turnover and function (Mochiki et al., 
2011). Supplementing glutamine for gastrointestinal discomfort has been shown to improve the 
intestinal mucosal barrier by regulating the expression of genes and proteins that are involved in 
cell proliferation, differentiation, and apoptosis, protein turnover, anti-oxidative property, and 
immunity responses (Wang et al., 2014). 
 Glutamine is required for the normal production of immunoglobulin A in the intestines, 
which is a key factor in immune support (Resnick, 2010). Glutamine has been shown to have 
anti-inflammatory benefits in the intestinal tract (Ren et al., 2013) and can regulate the 
metabolism of intestinal bacteria in the digestive tract (Wang et al., 2014). LDH or Lactate 
Dehydrogenase is an enzyme that is released when tissues are damaged. LDH activity was 
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significantly decreased (p < 0.05) when participants were given antioxidants and glutamine 
(Ziegler, Seddiki, Marion-Letellier, Lavoinne, & Déchelotte, 2011). 
 Intestinal permeability and morphology was significantly improved with glutamine 
supplementation (Benjamin et al., 2012). Glutamine significantly improved motor activity in the 
duodenum after gastric surgery (Mochiki et al., 2011). When used at the right dose, glutamine 
can be protective and prevent the increasing intestinal permeability seen in patients that are 
chronically ill (De-Souza & Greene, 2005; Sevastiadou et al., 2011). The therapeutic dose varies 
greatly across each research study; however, the ACHIM’s protocol for restoring digestive health 
utilizes 2-3 grams. In practice, this has seemed to be the most beneficial at improving 
gastrointestinal symptoms while scientific evidence varies. By decreasing the intestinal 
permeability, glutamine can reduce the frequency of infections and reduce the translocation of 
intestinal bacteria and toxins (Camilleri, Madsen, Spiller, Van Meerveld, & Verne, 2012; De-
Souza & Greene, 2005).  
When intestinal permeability is improved, intestinal absorption is improved (Leite et al., 
2013). This is an important concept to understand when treating individuals with diarrhea. 
Diarrhea can cause decreased absorption of vitamins and minerals because the total transit time 
is increased. One study found that in patients with diarrhea, absorption was significantly 
improved with glutamine supplementation (Leite et al., 2013). Glutamine has the power to 
improve patients overall gastrointestinal function and health (Camilleri et al., 2012). Therefore, it 
is a key component of the restoring digestive health protocol.  
The FDA is heavily researching glutamine, with 174 studies being conducted regarding 
the effectiveness and safety of glutamine (Clinical Trials, n.d). Glutamine is shown to be safe 
with minimal to no risk factors even in studies conducted on premature infants (Sevastiadou et 
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al., 2011). Glutamine is not metabolized through the CYP 450 system; therefore it does not 
interact with medications that are metabolized in the CYP 450 system. According to Natural 
Medicines’ database, glutamine’s level of evidence is a grade A (strong scientific evidence) for 
burns and a grade B (good scientific evidence) for total parenteral nutrition during trauma or 
post-surgery and grade C (unclear or conflicting scientific evidence) for the critically ill, 
inflammatory bowel conditions, mood, malnutrition, septicemia, transplants, and 
supplementation in preterm and very low birth weight infants (Natural Standards, 2015a).   
Digestive Enzymes 
The concept of supplementing digestive enzymes is not new. For over seventy years 
scientist have been researching the benefits of digestive enzymes (Stout, 2013). As individuals 
age, the amount of digestive enzymes produced by the body declines. Supplementing digestive 
enzymes can improve digestion, reduce abdominal distress, and result in a greater assimilation of 
vital nutrients like vitamins K, D, and omega-3 and omega-6 (Stout, 2013). Protease helps the 
body breakdown protein and absorbs the essential nutrients in proteins (amino acids) 
(Stout, 2013; Whitcomb & Lowe, 2007). Lipase helps the body breakdown fatty acids, which is 
essential for the absorption of fat-soluble vitamins, such as, vitamin A, E, D, and K (Stout, 2013; 
Whitcomb & Lowe, 2007). Digestive enzymes allow the digestive tract to rest and recover.  
Adequate digestion is required for gastrointestinal health; inadequate digestive enzymes 
are correlated with malabsorption, food intolerance, food allergy, autoimmune, bacterial 
overgrowth, and gastrointestinal discomfort (Resnick, 2010).  In the small intestine, there are 
digestive enzymes that are produced by the pancreas for the hydrolysis of complex nutrients 
(Kaur & Sekhon, 2012; Whitcomb & Lowe, 2007). The main digestive enzymes that the body 
uses include protease, amylase, sucrase, lipase, lactase, and maltase (Kaur & Sekhon, 2012).  
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Digestive enzymes can be supplemented or found naturally in foods. Food enzymes are 
produced externally and are derived solely from raw foods like animal or plant products and 
supplements. Protease, lipase, amylase, bromelain, and cellulose are plant based while pepsin, is 
an animal based enzyme (Kaur & Sekhon, 2012). Naturally occurring food enzymes are found in 
bananas, papaya, kiwi, bee pollen, raw honey, avocado, grapes, pineapple, extra virgin olive oil, 
dates, and certain raw oils and sprouts (Kaur & Sekhon, 2012). Digestive enzymes particularly 
protease, bromelain, and lipase can be extremely beneficial in reducing symptoms and restoring 
a balanced digestive tract (Kaur & Sekhon, 2012). 
 Pancreatic enzyme products contain the active ingredient pancrelipase, a mixture of the 
digestive enzymes amylase, lipase, and protease (Kaur & Sekhon, 2012). Cellulase and protease 
have been shown to be beneficial in controlling candida overgrowth (Kaur & Sekhon, 2012). 
Cellulase enzyme breaks down fiber and it is the only digestive enzyme the body does not make 
(Kaur & Sekhon, 2012). The enzyme protease has the ability to hydrolyze protein. Protease has 
been used in clinics all over the world to break down Candida and prevent its overgrowth (Kaur 
& Sekhon, 2012). Lactase supplements are used to help treat lactose intolerance. Lactase 
chewable tablets consists of an enzyme that helps consume dairy foods without producing gas, 
cramps, bloating, or diarrhea in the patient (Kaur & Sekhon, 2012). Digestive enzymes are 
supplemented in combination with lipase to digest fat, amylase to digest starchy carbohydrates, 
and protease to digest protein.  
Digestive enzymes as supplements along with meals share the workload of body’s own 
pancreatic enzymes for digestion (Kaur & Sekhon, 2012). Pancreatic enzyme replacement 
therapy is currently the mainstay of treatment for nutrient malabsorption, secondary pancreatic 
insufficiency, cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer (Kaur & 
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Sekhon, 2012). Reported data demonstrated efficacy in reducing steatorrhea and fat 
malabsorption (Kaur & Sekhon, 2012).  
Digestive enzymes as supplements may bring improvement in health problems such as 
heartburn, indigestion, gastrointestinal reflux disease, diarrhea, constipation, diabetes, bloating, 
and host of other health problems (Kaur & Sekhon, 2012). Supplemental proteolytic enzymes are 
derived from plant and animal sources. Common proteases include bromelain from pineapple, 
papain and chymopapain from papaya (Kaur & Sekhon, 2012). The fungal protease from the 
Aspergillus oryzae fungi and the trypsin, chymotrypsin, and pancreatin usually from porcine or 
bovine origin (Kaur & Sekhon, 2012)  
The FDA currently has 3677 studies regarding the effectiveness and safety of digestive 
enzymes (Clinical Trials, n.d). According Natural Medicines’ database, digestive enzyme’s level 
of evidence is a grade C (unclear or conflicting scientific evidence) for digestive enzyme 
insufficiency, hiatal hernias, and recovery from surgery (pancreatic, gastrectomy) (Natural 
Standards, 2015c).  At Atlanta Center for Holistic and Integrative Medicine the most common 
digestive enzymes utilized in the restoring digestive health protocol are called GFCF Similase. 
This digestive enzymes is a purely plant based product that consists of protease I, II, III, IV, V, 
amylase, lipase I, II, phytase, lactase I, II, cellulose I, II, and sucrase. However, there are several 
other digestive enzymes available on the market including bromelain sources or betaine HCL. 
The specific digestive enzymes used in this study are not metabolized by the CYP 450 system; 
therefore they do not interact with medications that are metabolized by the CYP 450 system.   
Age 
 Patient age range most affected by Functional Gastrointestinal Disorders remains vague 
and inconsistent. Research studies have found a wide-range of ages affected from childhood to 
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adulthood. A case-control study of 23,471 diagnosed with Functional Gastrointestinal Disorders 
was conducted in the United Kingdom. The mean age for this study was 51.4 years old (Ford et 
al., 2014). A study examined the prevalence of Functional Gastrointestinal Disorders among 
3,976 adolescents (10-17 years old) from 40 different schools. The study found that 552 students 
met the criteria for Functional Gastrointestinal Disorders. Although this study was conducted on 
adolescents, the results showed that the prevalence of Functional Gastrointestinal Disorders 
significantly increased as the adolescents aged (Sagawa et al., 2013). A European study 
examined 199 patients with Functional Gastrointestinal Disorders and found the mean age to be 
50 years old, ranging from 21-85 years old (Lahner et al., 2013). Another study examined 3,600 
individuals with Functional Gastrointestinal Disorders (Ford et al., 2014). The mean age for 
irritable bowel syndrome, functional diarrhea, and chronic idiopathic constipation was 38-42 
years old, 48 years old, and 52 years old respectively (Ford et al., 2014). Other studies have 
found that individuals younger than 50 years old are affected by irritable bowel syndrome more 
frequently (Scalera & Loguercio, 2012). As evident by the supporting studies, Functional 
Gastrointestinal Disorders do not discriminate, affecting all ages.   
Gender 
Functional Gastrointestinal Disorders affect females more frequently than males, yet the 
etiology behind this remains unknown (Markert et al., 2014). Possible theories for the female 
predominance include hormonal variations and perceived stress. Ford et al. (2014) found females 
to suffer more frequently from Functional Gastrointestinal Disorders including irritable bowel 
syndrome, functional dyspepsia, and chronic idiopathic constipation. In Western countries, 
irritable bowel syndrome is more common in females with a one to three ratio of males to 
females (Scalera & Loguercio, 2012). One study found women to have a 20% higher rate of 
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ambulatory visits related to gastrointestinal symptoms than men (Myer et al., 2013). A study 
conducted on adolescent found females to have a significantly higher prevalence of Functional 
Gastrointestinal Disorders compared to male students (Sagawa et al., 2013). 
 In contrast, an epidemiological study was conducted in Mexico to determine the 
prevalence of Functional Gastrointestinal Disorders. This study found that all Functional 
Gastrointestinal Disorders were equally prevalent among both genders except for irritable bowel 
syndrome and functional constipation which were found to be more prevalent in women (López-
Colombo et al., 2012). A large Internet survey was conducted in Japan to evaluate the lifestyle of 
individuals suffering with Functional Gastrointestinal Disorders (Miwa, 2012). The results of 
this study showed that the prevalence of functional dyspepsia and irritable bowel syndrome were 
significantly higher in women than males (Miwa, 2012). A study conducted on 31,866 U.S 
military personnel diagnosed with Functional Gastrointestinal Disorders found an overall higher 
incidence of Functional Gastrointestinal Disorders among females compared to males (Porter et 
al., 2011). Specifically, this study found a seven-fold higher rate of functional constipation 
among females compared to males (Porter et al., 2011). The case-control study conducted in the 
United Kingdom found a higher prevalence of females diagnosed with Functional 
Gastrointestinal Disorders (66.1%) (Ford et al., 2014). Another study conducted in Europe, 
found a female predominance (75.9%) when assessing 199 individuals with Functional 
Gastrointestinal Disorders (Lahner et al., 2013).  
Ethnicity 
There are limited studies assessing the role ethnicity plays on Functional Gastrointestinal 
Disorders. One study found that there were not any significant differences in ambulatory visits 
related to gastrointestinal symptoms between Caucasians and African Americans (Myer et al., 
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2013). Ford et al. (2014) found the majority of irritable bowel syndrome (87.4%) and chronic 
idiopathic constipation (88.9%) patients to be Caucasians. 
Weight and Waist Circumference 
The majority of the studies related to Functional Gastrointestinal Disorders, found that 
individuals that are overweight or obese suffer from Functional Gastrointestinal Disorders 
symptoms more frequently. A study was conducted on 450 children with 42% overweight or 
obese and 58% normal weight (Phatak & Pashankar, 2014). The results of this study found that 
in children, obese and overweight participants (47%) had a higher prevalence of Functional 
Gastrointestinal Disorders than normal-weight children (27%) (Phatak & Pashankar, 2014). A 
study conducted on 199 European adults diagnosed with Functional Gastrointestinal Disorders 
found the average body mass index to be 39.2, which is considered class II obesity (Lahner et al., 
2013).  
An increased weight circumference is associated with an increased risk of irritable bowel 
syndrome (Lee et al., 2015). A descriptive study was conducted in Turkey to evaluate how 
obesity affects gastrointestinal quality of life (Yilmaz, 2013). The results of this study found that 
obese patients suffer from gastrointestinal symptoms more frequently and have a decreased 
quality of life based on the Gastrointestinal Quality of Life Index (Yilmaz, 2013). 
A prospective cohort study examined 35,447 adults to examine the relationship between 
BMI and Functional Gastrointestinal Disorders (Le Pluart et al., 2015). This study found that 
females with a high BMI had a significantly increased risk for functional diarrhea; however both 
high and low BMIs were shown to have an increased risk for functional dyspepsia (Le Pluart et 
al., 2015). In men, those with a lower BMI were found to have a greater risk for irritable bowel 
syndrome (Le Pluart et al., 2015). A smaller case-controlled study with 336 individuals found 
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that overall BMI was not a good predictor for irritable bowel syndrome; yet, abdominal fat and 
an increased waist circumference were better predictors of irritable bowel syndrome, specifically 
irritable bowel syndrome with diarrhea (Lee et al., 2015).  
Quality of Life 
 Several studies have been conducted to examine the correlation of Functional 
Gastrointestinal Disorders symptoms and quality of life. Adolescents suffering from Functional 
Gastrointestinal Disorders had a significantly lower quality of life score (Sagawa et al., 2013). 
Individuals suffering from Functional Gastrointestinal Disorders were shown to have 
impairments in sleep, eating habits, diet, exercise, and feelings of excessive stress (Miwa, 2012). 
A random sample of 1,001 Swedish adults was conducted to assess the impact functional 
dyspepsia has on quality of life (Aro et al., 2011). This study used the Short Form-36 
questionnaire to assess eight domains related to quality of life including physical, mental, and 
social aspects (Aro et al., 2011). The results of this study found a statistically significant impact 
on health-related quality of life (p < .05) in all the Short Form-36 domains except for Role 
Emotional (Aro et al., 2011). 
 Singh et al. (2012) conducted a study to examine the prevalence of somatic and 
psychiatric co-morbidities seen in patients with irritable bowel syndrome and how the disorder 
affects the participants’ quality of life. The study evaluated 184 participants diagnosed with 
irritable bowel syndrome and 198 controlled participants. Major depressive disorders, 
somatoform disorders, and panic disorders were more common in patients suffering from 
irritable bowel syndrome than in the controls (Singh et al., 2012). Quality of life was 
significantly lower in patients with irritable bowel syndrome when compared to the control 
group based on the World Health Organization (WHO) QOL-BREF (Singh et al., 2012).  
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Lackner et al. (2014) conducted a study with 234 individuals with irritable bowel 
syndrome to determine what factors reduced the individual’s quality of life. The results of this 
study found that fear of gastrointestinal symptoms related to irritable bowel syndrome was the 
most strongly associated with reduced quality of life (Lackner et al., 2010; Lackner et al., 2014). 
This factor was shown to triumph other factors, such as symptom severity, personality, 
sociodemographics, and overall emotional wellbeing (Lackner et al., 2010.; Lackner et al., 
2014).  
Stress 
 Those suffering from Functional Gastrointestinal Disorders are thought to have higher 
stress levels. Markert et al. (2014) conducted a study on two different universities in Switzerland 
to evaluate the association between stress and digestive symptoms. A total of 1901 participants 
completed the survey online with 1857 participants included in the study. Of the sample, 62.78% 
met the criteria for at least one Functional Gastrointestinal Disorders. The results of this study 
found that those with higher levels of self-reported stress had worse symptoms (Markert et al., 
2014).  
 Another study was conducted on 105 patients diagnosed with irritable bowel syndrome to 
examine the association between social support and the severity of irritable bowel syndrome 
(Lackner et al., 2010). The Perceived Stress Scale was used to measure how the participants 
appraised the amount of stress in their life. This study found that perceived stress significantly 
predicted pain severity (p < 0.05) (Lackner et al., 2010).  
Duration of Symptoms 
 When conducting the literature review, minimal information was obtained regarding the 
mean duration of Functional Gastrointestinal Disorder symptoms. However, the majority of the 
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studies used the diagnosis of Functional Gastrointestinal Disorders as having experienced 
functional symptoms involving the upper and/or lower gastrointestinal tract over the past 6 
months at least one time per week (Lahner et al., 2013).   
Number of Attempted Treatments 
 Conventional or standard treatment for functional gastrointestinal disorders is symptom 
management through laxatives, antidiarrheal, antispasmodics, or antidepressants. It is estimated 
that less than 50% of patients with irritable bowel syndrome are satisfied with their treatment 
plan (Aucoin, 2014). Therefore, 21-51% of irritable bowel syndrome patients are seeking 
complementary and alternative modalities (Aucoin, 2014). Historically, treatment of Functional 
Gastrointestinal Disorders focused on symptom relief through conventional medications. 
However, symptom control has not been effective means for managing the symptoms associated 
with Functional Gastrointestinal Disorders (Lahner et al., 2013).  
Failure of conventional therapy may be related to the poorly understood pathology and 
the vast psychological factors associated with Functional Gastrointestinal Disorders (Lahner et 
al., 2013). Due to the lack of success with conventional therapy, individuals suffering from 
Functional Gastrointestinal Disorders are beginning to try complementary and alternative 
medicine therapies. A study was conducted on 199 patients diagnosed with Functional 
Gastrointestinal Disorders to examine patients’ current treatment modalities for the management 
of Functional Gastrointestinal Disorders (Lahner et al., 2013). The results show that roughly half 
of the patients in the study used some sort of CAM (48.7%) including herbal medicine (36.7%) 
and homeopathy therapy (17.1%) (Lahner et al., 2013). Natural remedies include a dietary 
approach (64.3%), exclusion diets (39.7%), probiotics (31.7%), and prebiotics (22.6%). Two-
thirds of the patients used more than one treatment option for the management of symptoms: 
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34.7% conventional medications, CAM, and dietary supplements, 17.1% conventional 
medications and dietary supplements, 10.1% diet and CAM, and 5% conventional medications 
and CAM (Lahner et al., 2013). When examining conventional medications, the largest drug 
class utilized includes proton pump inhibitors (42.2%), antispasmodics (34.2%), anti-acids 
(29.1%), and prokinetics (29.1%) (Lahner et al., 2013).  
Theoretical Framework 
Betty Neuman’s Healthcare System Model 
 Understanding the basic assumptions of Betty Neuman’s Healthcare System Model is 
important when restoring digestive health.  Betty Neuman’s Healthcare System Model stresses 
the fact that each client’s system is unique; therefore, no two patients are created equal. Within 
each system there are known, unknown, and universal stressors that occur within each client’s 
life (Neuman, 1989). These stressors have the ability to disturb the client’s stability. The term 
“wellness” can be thought of as a continuum with optimal wellness on one side and illness on the 
other side. When caring for patients with functional gastrointestinal disorders, the goal is 
optimizing their wellness and reducing their gastrointestinal symptoms. Individuals are 
continuously shifting along the continuum depending on internal and external stressors. 
Examples of internal stressors include anxiety and depression. External stressors include job 
stress, family stress, and social stress. At times, food sensitivities or environmental triggers could 
be aggravating gastrointestinal symptoms. Reducing known and unknown stressors can 
ultimately improve the patient’s symptoms and healthcare outcomes.  
 Major concepts and terms explained in this theory include content, basic structure or 
central core, degree to reaction, entropy, negentropy, open systems, stability, and stressors. 
Content is the variables within each person’s interaction with the internal and external 
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environment that comprise the whole person’s system (Neuman, 1989). In patients with 
Functional Gastrointestinal Disorders, stress may be a variable that is compromising the whole 
person’s system. The basic structure or central core is made up of the basic survival factors, 
such as, temperature and genetic structures (Neuman, 1989). Patients with digestive dysfunction 
have basic structures or survival factors embedded in their system to help overcome illnesses. 
For example, if patients are exposed to bacteria via ingestion, the body’s natural mechanism is to 
speed up motility to eliminate the bacteria. This can cause diarrhea or loose stools. Stability or 
homeostasis is achieved when the energy that is available exceeds that being used by the system 
(Neuman, 1989). This process is constantly changing to maintain a state of balance with input, 
output, feedback, and compensation (Neuman, 1989). Stability or homeostasis is achieved in 
patients with Functional Gastrointestinal Disorders when there is resolution of gastrointestinal 
symptoms and balance is achieved. The degree to reaction is the amount of each system that is 
unstable due to the negative impact of stressors (Neuman, 1989). In patients with Functional 
Gastrointestinal Disorders the higher the degree of reaction, or the negative factors that cause the 
system to become unstable, the worse the gastrointestinal symptoms become. Entropy is the 
process of energy depletion and disorganization that ultimately moves the system towards illness 
or in this case functional gastrointestinal disorder symptoms (Neuman, 1989). Negentropy is the 
process of energy conservation that increases the organization and complexity of the system 
(Neuman, 1989). This makes the system more stable allowing the body to achieve a higher 
degree of wellness.  
 Neuman’s model relies heavily on the concept of an open system. An open system is 
where all systems are in continuous interaction with each other and the environment (Neuman, 
1989). In the human body, the digestive system interacts with numerous other systems including 
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the pancreas, gallbladder, and liver. The term reconstitution is used when the system has 
returned and maintained stability. Betty Neuman believes reconstitution is possible. 
Reconstitution typically occurs after an individual has defined and reduced his or her individual 
stressor. The end goal of Betty Neuman’s Theory is stability, which is a state of balance and 
harmony. This is achieved when the patient adequately copes with stressors and maintains an 
optimal level of health and wellness. Overtime, this preserves the systems overall integrity.  
 When considering Betty Neuman’s Healthcare System Model, it is important to 
remember that each client’s system is in a state of dynamic and constant energy exchange with 
the environment. Research suggests that internal and external stressors can worsen 
gastrointestinal symptoms. As previously stated, internal stressors could be anxiety, emotional 
stress, or physical illness. There is clear evidence that anxiety and depression are positively 
correlated with abdominal pain (Walter et al., 2013). External stressors may be family illnesses, 
job deadlines, or schoolwork. There are several promising treatment options for reducing these 
stressors, such as mindfulness programs and cognitive behavior therapy. Studies have found that 
mindfulness programs can improve irritable bowel syndrome symptoms (Kearney, McDermott, 
Martinez, & Simpson, 2011). Mindfulness programs have the power to reduce the negative 
effects of external and internal stressors. GI-specific anxiety has been used to describe thoughts, 
emotions, and behaviors that revolve around the fear of developing gastrointestinal symptoms 
(Kearney et al., 2011). This is an endogenous stressor that can worsen intestinal function and 
cause visceral pain (Kearney et al., 2011). Research suggests that mindfulness training has been 
shown to significantly reduce bowel symptom severity, improve health-related quality of life, 
and reduce distress (Gaylord et al., 2011). The results found in this study showed that the 
positive benefits persisted for 3 months after treatment with mindfulness training (Gaylord et al., 
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2011). Therefore, this is a cost-effective treatment with long lasting impact in the patients overall 
health. Another study found that increased perception of social support improved irritable bowel 
syndrome symptoms, specifically abdominal pain (Lackner et al., 2010). The social support 
seemed to reduce stress levels and ultimately improve irritable bowel syndrome symptoms 
(Lackner et al., 2010).  
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Figure 1. Applying Betty Neuman’s Health Systems Model. Adapted from Neuman (1989).   
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CHAPTER III 
Project Description and Methodology 
Objectives  
 The specific aim of this project was to outline the healthcare problems associated with 
Functional Gastrointestinal Disorders and to explore the effectiveness of a gastrointestinal 
protocol implemented at Atlanta Center for Holistic and Integrative Medicine. This protocol was 
designed to help restore digestive health.  
The purpose of the proposed translational research project was to determine if adult 
patients with Functional Gastrointestinal Disorders would report improved symptoms based on 
the Gastrointestinal Quality of Life Index after eight weeks of probiotics, digestive enzymes, and 
glutamine.  Each one of the components of this intervention served a unique purpose. The 
probiotics were used to help improve the bacterial gut morphology. The digestive enzymes 
helped facilitate digestion and absorption of nutrients from food, which allowed the digestive 
tract time to rest and heal. Glutamine was used to calm inflammation, improve intestinal 
permeability, and heal the intestinal lining. The primary objective of this research project was to 
quantify a well-established protocol utilized at the Atlanta Center for Holistic and Integrative 
Medicine. This practice’s protocol focuses heavily on restoring digestive function, since a 
normally functioning digestive tract is essential for overall health and wellbeing.  
Project Design and Procedures 
 The design for this translational research project was a prospective cohort study. The 
subjects in this study were examined at baseline, weekly, and after eight weeks of intervention 
with probiotics, digestive enzymes, and glutamine.  This design was appropriate to examine the 
effectiveness of the restoring digestive health protocol in adults with gastrointestinal symptoms. 
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Below is a brief overview of the project design. Each component will be further discussed in the 
following sections. A flow diagram for the research study can be found under Appendix A.  
Consent from Atlanta Center for Holistic and Integrative Medicine and Georgia College 
and State University Institutional Review Board was obtained prior to beginning the recruitment 
of participants for this study. After receiving IRB approval, the researcher enrolled subjects that 
met the inclusion criteria. Recruitment was initiated in May 2015 from Atlanta Center for 
Holistic and Integrative Medicine. The subjects were virtually recruited through ACHIM’s 
newsletters and Facebook wall. An example of the flyer used in the newsletter and on Facebook 
can be found under Appendix B. Participants that expressed interest in participating in the 
research study received a detailed informed consent to his or her email. An example of the 
informed consent can be found in Appendix C.  
If the participants would like to participate after reading the full informed consent, the 
consent was signed and either faxed or scanned directly to the researcher. The researcher 
reviewed each informed consent to ensure the participant answered “no” to the alarming 
symptoms based on the Rome III criteria. If a participant answered “yes” to any of the exclusion 
criteria, they were not allowed to participant in the study. Once the informed consent was signed 
and received by the researcher, the qualified participants received a welcome email with detailed 
instructions for the research study. Each subject voluntarily participated with the ability to cancel 
his or her participation at any time during the study without reason. Participants that lived close 
to ACHIM had the option to personally pick up the supplements (probiotics, digestive enzymes, 
and glutamine) and those that did not live close had the supplements mailed directly to his or her 
house at the researcher’s expense.  
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The welcome email included links to an introduction video, a video demonstrating how to 
accurately measure weight and waist circumference, baseline questionnaires administered 
through survey monkey and a study checklist. The introduction video clearly outlined the 
purpose of the research study and an official thank you for his or her time and participation. The 
video explained the expected time commitment, his or her rights to withdraw at any time, the 
confidentiality in data collection, analysis and reporting of findings. The next video explained to 
each participant the importance of consistency for weekly weigh-ins and waist circumference 
measurements. The video outlined (step by step) how to accurately measure his or her waist 
circumference and weight. An identification number was assigned to each participant prior to 
starting data collection. All participants were prompted to put in their unique identification 
number on each electronic questionnaire and weekly update. Only the principal investigator had 
access to the participant’s identity and identification number. All information obtained was 
encrypted and password protected on a secure network. The initial assessment questionnaire 
included demographic data (age, gender, and ethnicity), duration of symptoms, number of 
attempted treatments, waist circumference, weight, Perceived Stress Scale, and the 
Gastrointestinal Quality of Life Index. The baseline questionnaire was completed prior to 
starting the intervention of probiotics, digestive enzymes, and glutamine. The study checklist 
could have been printed and kept as a reminder for each step during the research study. An 
example of the study checklist can be found under Appendix D.  
To enhance compliance and active involvement, each participant received a weekly email 
through survey monkey. Survey monkey was used to collect the data because it has the ability to 
automatically sync with SPSS version 22.0. The weekly questionnaire would prompt individuals 
to enter their unique identification number prior to answering the four questions: (1) how many 
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supplements did you miss in the previous week; (2) what is your current weight; (3) what is your 
current waist circumference; and (4) any additional comments at this time. The purpose of the 
weekly weight and waist circumference was to determine the timing of significant change, 
minimize missed supplements, and encourage active participation. If participants missed more 
than 2 weekly entries, their data was excluded. However, if a participant missed a Wednesday 
survey the researcher sent two additional reminders to their email 24 hours apart.  No participant 
was penalized for missing supplements because research shows even individuals on crucial 
medications can occasionally forget their daily dose. A study was conducted to assess how often 
individuals with epilepsy forgot their medication (Paschal, Rush, & Sadler, 2014). The results of 
the study found that 66% of the 180 subjects reported not taking their medication on a monthly 
basis due to “forgetfulness” (Paschal et al., 2014). 
After the 8-week intervention of probiotics, digestive enzymes, and glutamine, a post-
intervention questionnaire was administered through the participants preferred email. This email 
included the Perceived Stress Scale, Gastrointestinal Quality of Life Index, waist circumference, 
and weight. All data collected was analyzed to answer each specific research question and the 
results were disseminated at the Georgia Nursing Leadership Coalition’s Doctorate Symposium 
in November of 2015. All data was reported in aggregate to keep patient confidentiality. 
Collected data will be kept on a secure network for five years.  
Project Site 
 The researcher for this project is a Family Nurse Practitioner at Atlanta Center for 
Holistic and Integrative Medicine, located in Atlanta, Georgia. This practice is a unique fee-for-
service practice with three physicians, two nurse practitioners, a registered dietician, a 
nutritionist, an acupuncturist and an Ayurveda therapist. The primary focus of the practice is to 
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integrate both mainstream conventional medicine and alternative therapies to heal the whole 
person and uncover the root cause of patients’ symptoms.  
The Founder of the Center, Dr. Tasneem Bhatia was a committee member for this 
translational research project. Letters of Support and the Statement of Mutual Agreement were 
obtained from Atlanta Center for Holistic and Integrative Medicine prior to beginning the study.   
Sample 
From May to June 2015, a convenience sample was obtained from the Atlanta Center for 
Holistic and Integrative Medicine (ACHIM). This practice sends out a virtual newsletter to over 
5,000 people and it has a Facebook group with over 20,000 followers. Both the virtual newsletter 
and Facebook group were used to recruit subjects. While the primary researcher of this project 
works at ACHIM, she did not personally recruit patients to ensure participants did not feel 
coerced to participate. All subjects voluntarily enrolled in the study. Approval from the 
Institutional Review Board was obtained prior to recruiting subjects. Informed consent was 
obtained from each participant prior to data collection.  
Inclusion Criteria. Adult patients (males and females) 18 to 65 years old with current 
complaints of gastrointestinal symptoms including, but not limited to constipation, abdominal 
pain, diarrhea, reflux, or bloating. Digestive symptoms had to be functional without a known 
organic cause. Each participant was required to have a physical exam within the 12 months of 
the research study. Participants must have been proficient in English and have access to email, a 
scale, and a tape measure (in centimeters). Each participant had to be able to follow directions. 
Participants who were willing and able to participate in the full course of the study signed the 
informed consent.  
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Exclusion Criteria. Exclusion criteria included patients younger than 18 years old or 
older than 65 years old, pregnant or nursing women, and any symptoms which may indicate 
significant health related problems based on the alarming symptoms in the Rome III Criteria. 
The primary researcher screened all participants based on the Rome III Criteria for alarming 
symptoms. The alarming symptoms used from the Rome III Criteria include: blood in stool, 
black stools, vomiting blood, anemia unrelated to menstrual cycle, fever, unintentional weight 
loss of greater than 10 pounds, over the age of 50 with a major change in bowel movements, 
persistent or worsening hoarseness of the voice, worsening throat pain over the past 3 months, 
chest pain on exertion, and difficulty swallowing. Participants under 18 years old were excluded 
from the study to avoid having to take into account growth and developmental factors. All 
participants diagnosed with an organic gastrointestinal disease were excluded including peptic 
ulcers, Crohn’s disease, ulcerative colitis, or gastrointestinal tumors. Any participants that self-
reported diseases that alter the function of the liver or kidney were excluded from the study 
including hepatitis, cirrhosis, non-alcoholic fatty liver disease, kidney disease, or organ 
transplants.  
Sample size. The sample size was determined based on Warner’s decision rule for 
calculating sample sizes with a power of 0.80 and an alpha of 0.05 (Warner, 2008) to test 
significance with R2 with a medium effect (F2-0.15) the total N required was 80 + k where k was 
the number of independent variables. In this study, sample size was based on 10 independent 
variables. Based on Warner’s formula, the sample size needed is 90 adult subjects with 
functional gastrointestinal symptoms. This study had 98 enroll in the study and 86 complete the 
entire 8-week intervention.   
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Supplements 
 The specific brands used in the restoring digestive health protocol at Atlanta Center for 
Holistic and Integrative Medicine include Metagenics, Integrative Therapeutics, and 
Orthomolecular. The same brands were used for this study for a number of reasons including the 
following: (a) to replicate the protocol as closely as possible; (b) to keep consistency among each 
participant; (c) to ensure the high quality supplements were used. The following products were 
donated for the research study: Glutagenics by Metagenics (glutamine powder), Orthobiotic by 
Orthomolecular (probiotic), GFCF Similase by Integrative Therapeutics (digestive enzymes). 
Since the products were donated, the study was free for participants. The researcher received no 
compensation by the companies and does not promote specific brands.  
Instruments 
 The instruments utilized in this study include the Gastrointestinal Quality of Life Index, 
the Perceived Stress Scale, weight, and waist circumference. The following section discusses 
these instruments.  
Gastrointestinal Quality of Life Index. Defining distress is often difficult because it is a 
subjective term. Researchers often validate distress by quantifying and measuring the patients’ 
quality of life through appropriate instruments, such as the Gastrointestinal Quality of Life Index 
(GQOLI) as used in this study. It is evident that there is a direct correlation between 
gastrointestinal symptoms and quality of life (Naliboff et al., 2012; Tielemans et al., 2013). 
Unfortunately, there is limited research investigating the impact of subjective distress and 
Functional Gastrointestinal Disorders (Markert et al., 2014). The instrument utilized in this 
translation research project was the Gastrointestinal Quality of Life Index (Eypasch et al., 1995). 
Prior to using this tool, permission was obtained via email from the instrument’s designer. The 
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Gastrointestinal Quality of Life Index was developed in 1995 by 4 surgeons and 3 
methodologists (Eypasch et al., 1995). This instrument was developed to help healthcare 
providers better measure quality of life specific for the gastrointestinal tract.  The GIQLI is a 36-
Likert item GI-specific Health Related Quality of Life (HRQL) instrument designed to assess 
HRQL in clinical practice and clinical trials of patients with gastrointestinal disorders (Eypasch 
et al., 1995). The GIQLI has five sub scales (Gastrointestinal symptoms, Emotion, Physical 
Function, Social Function, and Medical Treatment) as well as a total score (Eypasch et al., 1995). 
Each of the items was scored on a five point Likert scale with a range from 0 (most negative) to 
4 (most positive). Possible total scores ranged from 0-144 points (Eypasch et al., 1995). The 
Intraclass Correlation Coefficient (ICC) was .92 which denotes a high level of reliability and the 
internal consistency based on Cronbach’s Alpha ranged from .90 to .93 (Eypasch et al., 1995). 
This instrument has been used and validated in a variety of cultures.  
In the United States, a study was conducted to evaluate gastrointestinal symptoms in liver 
transplant patients after the conversion from mycophenolate mofetil to enteric-coated 
mycophenolate sodium (Toledo et al., 2012). The GIQLI was administered to the participants at 
baseline and three months later. The instrument was able to capture significant improvements 
from baseline to three months in gastrointestinal quality of life (p  <  .05) (Toledo et al., 2012). 
However, this article did not report the internal consistency. 
A pilot study was conducted in the United States to assess the quality of life in pediatric 
patients after a laproscopic cholecystectomy for biliary dyskinesia (Maxwell, Thompson, 
Richmond, McCagg, & Ubert, 2012). This study administered the GIQLI to both the parents and 
children. The results were similar between the parents and the children indicating homogeneity (r  
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= .93) (Maxwell et al., 2012). The study found those patients suffering from long-term 
symptoms have lower quality of life than those with symptom resolution (Maxwell et al., 2012).  
Machnicki et al. (2008) conducted a longitudinal, observational study involving five 
South American centers. The purpose of this study was to evaluate the reliability and validity of 
two different GI-specific outcome measures (Gastrointestinal Symptom Rating Scale (GSRS) 
and Gastrointestinal Quality of Life Index) in renal transplant patients. Each participant 
completed the GSRS, GIQLI, and Psychological General Well-Being Index at baseline and at 4 –
6 weeks. The GIQLI total and sub scale scores demonstrated excellent internal consistency 
reliability (.78 - .96) (Machnicki et al., 2008).  
Borgaonkar & Irvine (2000) conducted a thorough literature review to evaluate ways to 
reliably measure quality of life as it relates to gastrointestinal and liver disorders. The results of 
the literature review found the GIQLI to be both valid and reliable. Construct validity was 
supported by demonstrating a reasonable correlation with the Spitzer quality of life index (r = 
.53) and the Bradburn aVect balance scale (r = .42) in 204 German patients with a variety of GI 
illnesses (Borgaonkar & Irvine, 2000). The test-retest reliability was found to be excellent with 
an ICC of .92 as was internal consistency (  > .90) (Borgaonkar & Irvine, 2000). 
A study was conducted in the Netherlands to validate the GIQLI for patients with 
periampullary tumors (van Dijkum et al., 2000). The GIQLI has been shown to be valid and 
reliable based on the Cronbach’s alpha of each sub-score including, total score (.93), physical 
well-being (.91), gastrointestinal digestion (.83), gastrointestinal defecation (.75), and mental 
well-being (.87) (van Dijkum et al., 2000).  
Sandblom et al. (2009) validated a Swedish version of the GIQLI in patients with 
gallstones. The purpose of this study was to evaluate the sensitivity to change, internal 
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consistency, and test–retest stability of the instrument on 187 consecutive patients who 
underwent planned cholecystectomy (Sandblom et al., 2009). Construct validity was assessed by 
comparing the GIQLI score with the SF-36 in a separate group of patients. The intraclass 
correlation was .85 (95% CI [.73–.92]) for the global score, .87 (95% CI [.76–.93]) for 
symptoms, .83 (95% CI [.70–.91]) for physical dysfunction, .68 (95% CI [.46–.81]) for 
emotional dysfunction, .63 (95% CI [.40–.79]) for social dysfunction, and .62 (95% CI [.38–.78]) 
for effect of medical treatment (Sandblom et al., 2009). The Cronbach’s alpha was .92 for the 
global score, .89 for symptoms, .84 for physical dysfunction, .83 for emotional dysfunction, and 
.77 for social dysfunction (Sandblom et al., 2009). Therefore, the Swedish version of the GIQLI 
was shown to be valid, reliable, and sensitive enough to yield significant results (p < .05) 
(Sandblom et al., 2009). 
Chen et al. (2005) conducted a study to evaluate the quality of life in patients who 
underwent laparoscopic versus open cholecystectomy. Each participant completed the GQLI 
preoperatively and at 2, 5, 10, and 16 weeks postoperatively (Chen et al., 2005). This instrument 
was shown to be a valid and reliable way to detect significant changes (p < 0.05) in 
gastrointestinal-specific quality of life after surgery (Chen et al., 2005). 
Perceived Stress Scale. The Perceived Stress Scale (PSS) is a self-reported questionnaire 
designed to measure the degree to which a person perceives a given situation as markedly 
stressful compared to the individual’s ability to cope (Cohen, Kamarck, & Mermelstein, 1983). 
The primary goal of the instrument is to provide a global and subjective way to measure 
perceived stress (Cohen et al., 1983) and to assess the general predisposition an individual may 
have to experience stress (Morgan, Umberson, & Hertzog, 2014). This instrument has been 
described as the most popular measure for perceived stress (Karam et al., 2012). The PSS has 
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been translated into over twenty-five languages including Arabic, Swedish, Spanish, Chinese, 
Japanese and Turkish versions (Andreou et al., 2011; Taylor, 2014). Currently, there are three 
versions of the PSS: the original 14-item scale (PSS-14), the 10-item scale (PSS-10), and the 4-
item scale (PSS-4) (Taylor, 2014).  
In previous studies, the PSS-14 was shown to have good internal consistency with a 
Cronbach alpha of .86 (Cohen et al., 1983). Through further investigating, the developers of the 
PSS-14 found four of the items to be poor indicators of perceived stress and created the more 
widely used and researched PSS-10 (Taylor, 2014). The PSS-10 is a 10-item Likert-type scale 
with answers ranging from 0 - 4 (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4 
= very often) (Barbosa-Leiker et al., 2013; Taylor, 2014). Number 4, 5, 7, and 8 are reverse-
scoring items (Taylor, 2014). Total scores are calculated after reversing positive items scores 
ranging from 0 - 40, with higher scores indicating greater perceived stress. 
The scale was first shown to be reliable when it was tested on a sample of college 
students in comparison to the life-event scores (Cohen et al., 1983). The results presented 
showed that the PSS was a better predictor of the outcomes related to stress than the life-event 
scores (Cohen et al., 1983). The results of the PSS were further strengthened with the correlation 
of elevated cortisol levels with higher PSS scores (Ezzati, 2013). Through the initial testing of 
the PSS, the internal consistency reliability coefficients for the negative subscale of PSS-14, 
PSS-10, and PSS-4 were .83, .83, and .67, respectively and the positive subscales of PSS-14, 
PSS-10, and PSS-4 were .86, .81, and .71, respectively. The total scores of the PSS-14 and PSS-
10 had similar internal consistencies with a Cronbach’s alpha of .83 and .82 respectively, 
however the PSS-4 was not found to be reliable with a Cronbach’s alpha of .68 (Andreou et al., 
2011; Cohen et al., 1983).  
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The scale was further assessed on healthy adults and found an adequate reliability with 
Cronbach’s alpha of .78 (Barbosa-Leiker et al., 2013). Another study found the PSS-10 to be a 
reliable tool when measuring perceived stress in pregnant women taking anti-depressants with a 
Cronbach’s alpha of .90 (Karam et al., 2012). Another study was seeking to validate the Swedish 
version of the PSS-10; the results showed that the PSS-10 presents normally distributed data, 
good internal reliability (  = .84), and good construct validity with anxiety (r = .68), depression 
(r = .57), and mental and physical exhaustion (r = .71) (Nordin, 2013).  Being that Nordin (2013) 
studied the reliability and validity of the PSS-10 twenty-five years after its development and with 
a different culture and still found comparable results, indicates that the PSS-10 is not culture-
sensitive rather it assesses the basic human reaction to stressful life events (Nordin, 2013). This 
instrument is broad and can be applied to a platitude of situations. It has been used as both an 
outcome variable and a predictor variable (Morgan et al., 2014).  
For the purpose of this study, the PSS-10 was used. As outlined, this instrument has been 
shown to be reliable and valid. It has been heavily researched in many different cultures and has 
few limitations. One identified limitation, which would be true to all instruments that measure 
stress is the gender bias. Females have been shown to have an overall higher level of stress than 
males, which may skew the results (Taylor, 2014). 
Weight. Each subject was required to have access to a scale and was asked to use that 
same scale over the eight-week period. Weights were recorded at baseline, weekly, and post-
intervention. Since each participant was weighing him or herself on a weekly basis, each scale 
was not calibrated. To enhance validity each participant received detailed instructions on how to 
accurately measure his or her weight. The most important factor when gathering accurate weight 
measurements was consistency. Therefore, each participant weighed his or herself on 
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Wednesday with the same scale, without clothing, and at the same time of the day. Wednesdays 
were chosen to prevent fluctuations in weight from the weekend.  
Jerome et al. (2014) conducted a longitudinal study to assess the accuracy of web-based 
self-reported weights. Each participant in the study received a digital scale for home use and 
instructions to weight themselves at the same time of day, in the same clothing, and with the 
same scale. The results of this study found that weight was significantly underestimated from 6 
months to 24 months (Jerome et al., 2014). 
Another study was conducted to validate self-reported weights and heights in avoiding 
diabetes after pregnancy (Paez, Griffey, Thompson, & Gillman, 2014). Each participant was 
mailed a digital scale with spare batteries and a printed protocol with weighing instructions. The 
women were instructed to weigh themselves in the morning before eating, drinking, or dressing. 
Scales were to be placed on a hard surface and calibrated by stepping on the scale and waiting 
for it to blink three times (Paez et al., 2014). The results found that the women under-reported 
their weight (Paez et al., 2014).  
Waist Circumference. Waist circumference was self-reported at baseline, weekly, and 
post-intervention. Each participant was required to watch the instructional video on how to 
accurately measure waist circumference prior to starting the study. For the purpose of the study, 
each waist circumference was measured (in centimeters) in line with the umbilicus and parallel 
to the floor. Participants were instructed to take two measurements back to back and report the 
average. Measurements were taken flush against bare skin, at the same time of the day, every 
Wednesday over the course of the study. Wednesdays were chosen to prevent fluctuations in 
weight from the weekend.  
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A study was conducted to assess the validity of self-reported waist circumference 
measurements in Thai adults (Lim, Seubsman, Sleigh, & Bain, 2012). The results of the study 
found self-reported waist circumference to be similar to the technicians waist circumference 
measurement with a concordance correlation coefficient from .84 to .90 (Lim et al., 2012). This 
study had subjects measure their waist circumference at the umbilicus with light clothing on 
(Lim et al., 2012).  
Another study was conducted to assess the validity of self-measured waist circumference 
in adults at risk of type 2 diabetes and cardiovascular disease (Ayala, Nijpels, & Lakerveld, 
2014). In this study, each participant received mailed instructions and a measuring tape. The 
instructions specified that the waist circumference should be taken around a bare belly just above 
the navel (Ayala et al., 2014). The results of this study found that participants on average over-
estimated their waist circumference (Ayala et al., 2014). 
Dekkers, van Wier, Hendriksen, Twisk, and van Mechelen (2008) conducted a study to 
assess the accuracy of self-reported body weight, height, and waist circumference in a Dutch 
overweight working population. The instructions were mailed to each participant along with a 
questionnaire. Participants were instructed to use a non-stretchable paper measuring tape to 
measure their waist circumference in centimeters. Subjects were instructed to measure their waist 
circumference at the mid-point between the lower border of the ribs and the upper border of their 
pelvis. Participants were advised to measure against bare skin during exhalation with feet 25-30 
cm apart. Subjects were to take two measurements back to back and report the average value 
(Dekkers et al., 2008). Waist circumference was significantly over-reported by an average of 1.1 
cm (Dekkers et al., 2008). 
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Research Questions 
 The specific aim of this project was to determine if adult patients suffering from 
Functional Gastrointestinal Disorders would report improved symptoms based on the 
Gastrointestinal Quality of Life Index after 8 weeks of probiotics, digestive enzymes, and 
glutamine. This specific gastrointestinal protocol is heavily used at Atlanta Center for Holistic 
and Integrative Medicine. Below is a list of the clinical questions examined.  
Pre-Intervention Clinical Questions 
1. What demographic factors (age, gender, ethnicity, duration of symptoms, and number of 
attempted treatments) are associated with a lower level of gastrointestinal quality of life? 
2. What is the association between patients’ perceived stress and gastrointestinal quality of 
life? 
3. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) what is the association of perceived stress on 
gastrointestinal quality of life?  
4. What demographic factors (age, gender, ethnicity, duration of symptoms and number of 
attempted treatments) are associated with an increased weight and weight circumference? 
5. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments), what is the association between perceived stress and 
waist circumference and weight?  
6. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments), is there an association between gastrointestinal quality 
of life and weight and waist circumference?  
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Post-Intervention Clinical Questions  
7. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there an 
association between patients' perceived stress and gastrointestinal quality of life? 
8. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
enzymes, and glutamine what is the association of perceived stress on gastrointestinal 
quality of life?  
9. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
enzymes, and glutamine, what is the association between perceived stress and waist 
circumference and weight?  
10. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive 
enzymes, and glutamine, what is the association between gastrointestinal quality of life 
and weight and waist circumference?  
11. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there a 
statistically significant change in the gastrointestinal quality of life, weight, waist 
circumference, and perceived stress? 
Dissemination 
The author of this research study disseminated the findings with a podium presentation at 
a conference at West Georgia College in November 2015. Understanding the importance of 
dissemination, the author of this research study plans to apply for publication in a variety of 
medical journals. 
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Data Analysis 
 The collected data was analyzed using Statistical Package for the Social Sciences (SPSS) 
software version 22.0. Data analysis began with an examination of missing data and standard 
data cleaning. Internal consistency reliability of all the instruments was determined for this 
sample. All interval/ratio variables were assessed for normality and measures of central 
tendency. Descriptive statistics were used to describe the demographics of the sample. Any 
instrument that was not completed fully by the participant was not used in the final analysis if 
greater than 20% of the data was missing. If less than 20% of the data on a single scale was 
missing, the mean sample replacement was used to replace the missing data. Statistical 
assumptions for all statistical tests were examined prior to addressing the research questions. 
Analysis Plan for Research Questions 
Research Question One: What demographic factors (age, gender, ethnicity, duration of 
symptoms, and number of attempted treatments) are associated with a lower level of 
gastrointestinal quality of life? 
Approach: Appropriate statistical analysis was selected depending on the level and normality 
of the data. Both age and gastrointestinal quality of life scores were normally distributed and 
interval/ratio level data, therefore Pearson’s correlational analysis was used to evaluate whether 
age was associated with a lower level of gastrointestinal quality of life. An independent samples 
t-test was used to test the association between gender, ethnicity, duration of symptoms, and 
number of attempted treatments and gastrointestinal quality of life.   
Research Question Two: What is the association between participants’ perceived stress and 
gastrointestinal quality of life? 
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Approach: Perceived stress was measured by the Perceived Stress Scale and gastrointestinal 
quality of life was measured by the Gastrointestinal Quality of Life Index. Both of these 
instruments were interval/ratio level data and normally distributed. Therefore, Pearson’s 
correlational coefficient was used to determine if there was an association between participants’ 
perceived stress and gastrointestinal quality of life.   
Research Question Three: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) what is the association of perceived 
stress on gastrointestinal quality of life?  
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and 
perceived stress on gastrointestinal quality of life after controlling for the independent variables.  
Research Question Four: What demographic factors (age, gender, ethnicity, duration of 
symptoms and number of attempted treatments) are associated with an increased weight and 
weight circumference? 
Approach: Appropriate statistical analysis was selected depending on the normality and level 
of data. Initially, all of the interval/ratio level data was normally distributed except for weight. 
After conducting a logarithm transformation, weight was normally distributed based on Fisher’s 
measure of skewness and kurtosis. Therefore, the association between age on weight and waist 
circumference was examined with Pearson’s correlational coefficient.  Ethnicity, duration of 
symptoms, and number of attempted treatments was grouped and coded dichotomously. 
Therefore, the association between gender, ethnicity, duration of symptoms, and number of 
attempted treatments on waist circumference/weight was tested with an independent t-test. The 
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association between duration of symptoms and number of attempted treatments on weight and 
waist circumference was verified with a one-way ANOVA.  
Research Question Five: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments), what is the association between 
perceived stress and waist circumference and weight?  
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, and number of attempted treatment on 
perceived stress and waist circumference/weight after controlling for the independent variables.  
Research Question Six: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments), is there an association between 
gastrointestinal quality of life and weight and waist circumference?  
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, and number of attempted treatments on 
gastrointestinal quality of life and waist circumference/weight after controlling for the 
independent variables.  
Research Question Seven: After 8-week treatment with probiotics, digestive enzymes, and 
glutamine, is there an association between perceived stress and gastrointestinal quality of life?  
Approach: Perceived stress was measured with the Perceived Stress Scale and 
gastrointestinal quality of life was measured with the Gastrointestinal Quality of Life Index. Both 
of these instruments were interval/ratio level data and normally distributed. Therefore, Pearson 
correlational coefficient was used to determine if there was an association between participants’ 
perceived stress and gastrointestinal quality of life.   
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Research Question Eight: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) after 8-week treatment with 
probiotics, digestive enzymes, and glutamine, is there an association between perceived stress 
and gastrointestinal quality of life? 
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and 
perceived stress on gastrointestinal quality of life after controlling for the independent variables. 
Research Question Nine: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) after 8-week treatment with 
probiotics, digestive enzymes, and glutamine, what is the association between perceived stress 
and waist circumference and weight?  
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and 
perceived stress on waist circumference/weight after controlling for the independent variables. 
Research Question Ten: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) after 8-week treatment with 
probiotics, digestive enzymes, and glutamine, what is the association between gastrointestinal 
quality of life and weight and waist circumference?  
Approach: A simultaneous multiple linear regression was conducted to test the relationship 
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and 
gastrointestinal quality of life on waist circumference/weight after controlling for the 
independent variables. 
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Research Question Eleven: After 8-week treatment with probiotics, digestive enzymes, and 
glutamine, is there a statistically significant change in the gastrointestinal quality of life, weight, 
waist circumference, and perceived stress? 
Approach: A paired samples t-test was used to evaluate whether there was significant 
changes in gastrointestinal quality of life, weight, waist circumference, and perceived stress after 
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CHAPTER IV 
Results 
 The results of this prospective cohort study examine the effects of probiotics, digestive 
enzymes, and glutamine on restoring digestive health in participants suffering from Functional 
Gastrointestinal Disorders. Findings reported here include descriptive information concerning the 
participants, reliability of the instruments, and data addressing the research questions.  
Data 
 Data screening was performed prior to conducting the statistical analysis.  All data was 
verified using a double entry method where two separate databases were created and compared.  
Any discrepancies were reconciled with the participants’ original data.  Examination of all 
continuous variables was conducted to determine distribution using descriptive statistics for 
central tendency and Fisher’s exact for skewness and kurtosis. The weekly surveys were 
examined and no participant missed more than three supplements per week. 
 The study’s instruments were examined for missing data. When participant’s had less 
than 20% of the scores missing on the perceived stress scale and gastrointestinal quality of life 
index, the sample means were substituted for those missing items (Shrive, Stuart, Quan, & Ghali, 
2006). In this research study no participant missed greater than 20% of the data in the Perceived 
Stress Scale (n = 0) or Gastrointestinal Quality of Life Index (n = 0). In the pre-intervention 
survey, the following measures were missing age (n = 1), weight (n = 1), waist circumference (n 
= 9), and duration of symptoms (n = 1). Since these variables are not part of a total score, the 
missing variables were left missing.  
Prior to answering the research questions, the variables were analyzed to see if they met 
the assumptions for an ANOVA and linear regression. Instead of including both weight and 
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waist circumference, only waist circumference was used to answer the clinical research questions 
and regressional analyses for a number of reasons: (1) waist circumference was normally 
distributed based on Fisher’s exact skewness statistic (2.13) and kurtosis (.44) (Munro, 2005), (2) 
waist circumference is a better indicator of bloating, and (3) waist circumference was strongly 
correlated with weight (r = 0.76, p < .001).  
Weight was not normally distributed based on Fisher’s exact skewness statistic (3.71) and 
kurtosis (.44) (Munro, 2005; Tabachnick & Fidell, 2006). Analysis of the data indicated that no 
values were three standard deviations from the mean; therefore no outliers were removed (Kim 
& Mallory, 2014). A statistical correction using an inverse natural logarithm was performed on 
the variable as recommended by Tabachnick & Fidell (2006).  After conducting the inverse 
natural logarithm weight was normally distributed based on Fisher’s exact skewness statistic 
(2.28) and kurtosis (1.13). The resulting mean was 2.17 (SD = 0.98). 
Duration of symptoms was initially divided into five different categories including: less 
than 1 year, 1-3 years, 4-6 years, 7-10 years, and greater than 10 years. In order to further 
analyze the data, the results were divided into two groups: those who have had symptoms less 
than 3 year and those that have had symptoms longer than 3 years. All analyzes were run using 
the data grouped as less than 3 years and longer than 3 years to meet the assumptions of the 
regression.   
The number of attempted treatments was initially divided into four categories including: 
no treatment, 1-2 different treatments, 3-5 different treatments, and greater than 5 treatments. To 
further analyze the data, the results were divided into two groups: those who have attempted less 
than 3 different treatments and those that have attempted more than 3 different treatments. All 
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analyzes were run using the data grouped as less than 3 different treatments and more than 3 
different treatments to meet the assumptions of the regression.   
Ethnicities were divided into two categories including minorities and Caucasians. 
Hispanic (n = 5) and Native American (n = 2) participants were included in the minority group 
with African Americans due to the small number of participants.  
The other variables including age, perceived stress, and gastrointestinal quality of life 
were normally distributed in this sample based on Fisher’s exact. Each participant made his or 
her own independent appraisal of their symptoms, all participants were mutually exclusive, and 
the Levene tests were not significant indicating homogeneity of the variances of the participants 
on the dependent variables (Munro, 2005).  
Pre-Intervention Sample Characteristics 
 The initial sample consisted of 98 adult participants suffering from Functional 
Gastrointestinal Disorders. The participants were recruited through Atlanta Center for Holistic 
and Integrative Medicine’s social media including Facebook and blogs. Each participant 
voluntarily enrolled in the study and was screened based on the inclusion and exclusion criteria. 
Informed consent was obtained on each participant prior to initiating the study.  
The initial study participants, as shown in Table 1, were 90.8% female (n = 89) and 
primarily Caucasian (n = 76). Prior to starting the study, the majority of participants had tried no 
more than five different treatment modalities to alleviate symptoms (78.6%). The participant’s 
gastrointestinal symptoms were chronic in nature with the majority of the participants suffering 
from gastrointestinal symptoms for greater than 10 years (33.7%) and very few participants 
suffering from symptoms for less than 1 year (4.1%).  
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Table 1 
Pre-Intervention Demographic Characteristics of Participants 
Variables N (%) Mean (SD) Range 























































Duration of Symptoms  


















Note. Participant numbers may vary from 98 as not all participants answered all questions.  
 
Description of Research Instruments (Pre-Intervention) 
 This section describes the study instruments, reliability in this sample, the mean scores, 
standard deviations and the percentage of study participants above the normal range (Table 2). 
Instruments used as a continuous variable were normally distributed except the original weight 
variable.  
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Table 2 
Description of Research Instruments (Pre-Intervention) 



























































53.34 (7.10) 33-68 0-76  0.668 
  
Waist Circumference.  Waist circumference was measured in centimeters. Participants 
were advised to measure their waist circumference at the same time of day. Waist circumference 
was measured parallel to the floor and in line with the umbilicus. Participants were instructed to 
measure waist circumference flush against bare skin. Waist circumference measurements ranged 
from 54-122 centimeters.  
RESTORING DIGESTIVE HEALTH  67 
Weight. Weight was measured in pounds with results ranging from 98-253 pounds. 
Participants were advised to measure on the same scale, at the same time of day, and in the same 
(or no) clothes to maintain internal consistency. Although only waist circumference was reported 
in the clinical research questions, the tests were run to examine weight and waist circumference 
to evaluate significance. Analyses were run using both the weight before transformation and after 
the log transformation to determine if there were any differences, none were noted.  
 Perceived Stress Scale. Participants suffering from Functional Gastrointestinal Disorders 
were evaluated for their perceived level of stress using the 10-item, Likert-type Perceived Stress 
Scale (Cohen & Williamson, 1988). Scores ranged from 2-29 with higher scores indicating 
higher levels of stress. The normative scores for females was 13.7 and for males was 12.1 
(Cohen & Williamson, 1988). In this sample, 68.3% of the participants’ scored above 13 on the 
Perceived Stress Scale.  Out of the nine males in this sample, 5 scored above 12.5 on the 
Perceived Stress Scale (55.6%). Out of the eighty-five females in this sample, 64 scored above 
14 on the Perceived Stress Scale (75.3%).  Cronbach’s alpha for the sample was an acceptable 
0.88 (Di Lorio, 2005). 
 Gastrointestinal Quality of Life Index. Participants suffering from Functional 
Gastrointestinal Disorders were evaluated for their gastrointestinal quality of life based on the 
Gastrointestinal Quality of Life Index (Eypasch, 1995). Scores ranged from 57-131 with lower 
scores associated with lower quality of life. The normative value for the Gastrointestinal Quality 
of Life index is 125.8 (Eypasch, 1995). In this sample, at baseline, 99% of the participants scored 
below 124 with only one participant scoring 131. Several other studies evaluating participants 
with gastrointestinal dysfunction had similar results where the study participants had 
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significantly lower levels of gastrointestinal quality of life than the normative levels in the 
healthy population (Damon et al., 2008; Shi et al., 2011; Wierdsma et al., 2009).  
The Gastrointestinal Quality of Life Index was divided into four subcategories including 
emotional, physical, social, and symptoms. Cronbach’s alpha for each subcategory and total from 
the sample is as follows: emotional (0.82), physical (0.79), social (0.65), symptoms (0.67), and 
total (0.87). For the purpose of this study, subcategories were not tested separately due to low 
reliability based on their Cronbach’s alpha scores (Di Lorio, 2005). The total Gastrointestinal 
Quality of Life Index score was normally distributed based on Fisher’s exact skewness statistic 
(1.2) and kurtosis (0.85) (Munro, 2005). The total Gastrointestinal Quality of Life Index score 
had an acceptable Cronbach’s alpha of 0.87 (Di Lorio, 2005).   
Pre-Intervention Clinical Research Questions 
The following research questions were conducted using the pre-intervention data 
findings.   
Results for Research Question 1  
Research Question 1: What demographic factors (age, gender, ethnicity, duration of 
symptoms, and number of attempted treatments) are associated with a lower level of 
gastrointestinal quality of life using the Gastrointestinal Quality of Life Index?   
Age. Correlational analysis was used to evaluate whether age was associated with a lower 
level of gastrointestinal quality of life. Data indicated that there was no statistically significant 
association between age and gastrointestinal quality of life scores (r = .022, p = .83). For the 
purpose of this study, all of the independent variables were included in the Pearson correlation as 
seen in Table 3.  
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Gender. An independent samples t-test was used to evaluate whether gender was 
associated with a lower level of gastrointestinal quality of life. The covariate, gender, was 
dichotomously coded 0/1 for “male” or “female”. The research found no statistically significant 
association between gastrointestinal quality of life scores between females (M = 94.64, SD = 
15.76) and males (M = 102.85, SD = 14.15); t (96) = 1.5, p = .14).  
Ethnicity. An independent samples t-test was used to test the association between 
ethnicity and gastrointestinal quality of life. The covariate, ethnicity, was dichotomously coded 
0/1 for “Caucasian” or “Minority”. There was statistically significant association between 
gastrointestinal quality of life and ethnicity. Minorities (M = 88.37, SD = 14.22) reported 
significantly lower gastrointestinal quality of life than Caucasians (M = 97.43, SD = 15.64); t 
(96) = -2.44, p = .02).  
Duration of Symptoms. An independent samples t-test was conducted to examine the 
association between duration of symptoms and lower gastrointestinal quality of life. The 
covariate, duration of symptoms, was dichotomously coded 0/1 for “less than 3 years” or 
“greater than 3 years”. There was no statistically significant association between less than 3 
years of symptoms (M = 94.86, SD = 18.06) and greater than 3 years of symptoms (M = 95.34, 
SD = 14.7; t (95) = -.137, p = .89).   
The analysis was verified with the initial data grouping for duration of symptoms (less 
than 1 year, 1-3 years, 4-6 years, 7-10 years, and greater than 10 years) with one-way ANOVA 
testing. No statistically significant differences were seen F (4, 92) = 2.06, p = .093.  
Number of Attempted Treatments. An independent samples t-test was conducted to 
examine the association between the number of attempted treatments and lower gastrointestinal 
quality of life. The covariate, number of attempted treatments, was dichotomously coded 0/1 for 
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“less than 3 treatments” or “greater than 3 treatments”. There was a statistically significant 
association between less than 3 attempted treatments (M = 100.33, SD = 15.57) and greater than 
3 attempted treatments (M = 91.37, SD = 14.79; t (96) = -2.91, p < .01) on gastrointestinal 
quality of life. Therefore, the participants that had attempted more than 3 different treatments had 
significantly lower gastrointestinal quality of life.  
The analysis was verified with the initial data grouping for the number of attempted 
treatments (no treatment, 1-2 different treatments, 3-5 different treatments, and greater than 5 
treatments) with one-way ANOVA testing. The overall F for the one-way ANOVA was 
statistically significant F (3, 94) = 2.82, p = .043. Post hoc testing was conducted using Tukey’s 
HSD tests with no statistically significant difference between groups (p = .11). 
Results for Research Question 2:  
Research Question 2: What is the association between participants’ perceived stress and 
gastrointestinal quality of life? 
Since there were similarities between these two instruments, correlations between the 
questions on the instruments were evaluated. Although there were several significant 
correlations, there were only two items that were moderately correlated (r < -.585). Correlational 
analysis was used to evaluate the association between participants’ perceived stress and 
gastrointestinal quality of life. Initial data screening indicated that both variables were normally 
distributed. There was a low negative correlation between the overall scores on the perceived 
stress and gastrointestinal quality of life scores (r = -.326, p = .001). Therefore, the more 
perceived stress participants reported the lower their gastrointestinal quality of life. Table 3 
reports the Pearson correlations between all the main variables in this study.  
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Table 3 
Pearson Correlations between the Major Variables (Pre-Intervention) 
 1 2 3 4 5 6 7 8 9 
1. Age -         
2. Gender .170 -        
3. Ethnicity -.161 .086 -       
4. Duration of 
Symptoms 
.086 .024 -.077 -      
5. Attempted 
Treatments 
.141 .210* -.006 .143 -     
6. Weight 
(Log)  
.083 -.369** .094 .003 -.111 -    
7. Waist 
Circumference  
.218* -.244 .078 .096 -.028 .761** -   
8. Perceive 
Stress Scale 
.035 .166 .097 .016 .163 .100 -.024 -  
9. 
Gastrointestinal 
Quality of Life  
.022 -.152 .241* .014 -.285** -.164 -.212* -.326** - 
Note: * p < .05, ** p < .01 
Results for Research Question 3:  
Research Question 3: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) what is the association of perceived 
stress on gastrointestinal quality of life?  
 Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration 
of symptoms, number of attempted treatments, and perceived stress) were examined for 
multicollinearity. There was only one statistically significant correlation between the 
independent variables including gender and number of attempted treatments (r = .21, p = .04). 
This was a weak correlation indicating multicollinearity was not a problem (Munro, 2005).  
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 A simultaneous multiple linear regression was conducted to control for each variables 
effect on each other and to test the relationship between age, gender, ethnicity, duration of 
symptoms, number of attempted treatments, perceived stress, and gastrointestinal quality of life. 
Regression results indicated that the model accounted for 22.1% of the variance in the perceived 
stress and gastrointestinal quality of life (R2= .221, R2adj= .168, F (6, 89)= 4.206, p < .01). Table 
4 summarizes the multiple regression analysis.  
 The results of this simultaneous regression report there are three statistically significant 
predictors of gastrointestinal quality of life including: ethnicity, perceived stress, and attempted 
treatments. Minorities, higher levels of perceived stress, and greater than 3 attempted treatments 
were associated with lower gastrointestinal quality of life after controlling for the other 
independent variables. Therefore, gastrointestinal quality of life is negatively correlated with 
perceived stress; as the participants reported higher levels of perceived stress their 
gastrointestinal quality of life decreased.  
Table 4 








Std. β weights 
 
   t 
 
p value 
Constant 119.97  12.16 .00 
Age .095 .066 .673 .503 
Gender -2.893 -0.54 -.545 .587 
Ethnicity -7.303 -.196 -2.03 .045* 
Perceived Stress -.845 -.288 -2.98 .004** 
Attempted Treatments -6.901 -.219 -2.23 .028* 
Duration of Symptoms 1.267 .037 .391 .697 
Note: * p < .05, ** p < .01 
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Results for Research Question 4:  
Research Question 4: What demographic factors (age, gender, ethnicity, duration of 
symptoms and number of attempted treatments) are associated with an increased waist 
circumference?  
Age and waist circumference was normally distributed and interval/ratio level data 
therefore the association between age and waist circumference was tested with Pearson’s 
correlation coefficient. An independent samples t-test was conducted to test the association 
between gender, ethnicity, duration of symptoms, and number of attempted treatments on waist 
circumference. The only statistically significant association was between gender and waist 
circumference with males having a larger waist circumference than females.  See table 5 for a 
summary of the independent samples t-test and Pearson correlation for the analysis.   
Table 5 
Examining Association of Age, Gender, Ethnicity, Duration of Symptoms, and Number of 
Attempted Treatments on Waist Circumference  
 
Variable M (SD) t r P value 
Age 
 






















Duration of Symptoms 
Less than 3 years 









Number of Attempted Treatments 
Less than 3 








Note: *p < .05 
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Results for Research Question 5:  
Research Question 5: Controlling for demographic variables (age, gender, ethnicity, duration 
of symptoms, and number of attempted treatments), what is the association between perceived 
stress and waist circumference and weight?  
In this study, there was no statistically significant association between perceived stress and 
waist circumference (r = -.024, p = .822), therefore a simultaneous multiple linear regression 
controlling for the independent variables was not conducted.  
Results for Research Question 6:  
Research Question 6: Controlling for demographic variables (age, gender, ethnicity, duration 
of symptoms, and number of attempted treatments), is there an association between 
gastrointestinal quality of life and waist circumference?  
Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration of 
symptoms, number of attempted treatments, and gastrointestinal quality of life) were examined 
for multicollinearity. Although there were three statistically significant correlations, the strengths 
of the correlations remained low (r < -.285, p < .01). This is a low relation indicating 
multicollinearity was not a problem (Munro, 2005).  
A simultaneous multiple linear regression was conducted to test the relationship between age, 
gender, ethnicity, duration of symptoms, number of attempted treatments, and gastrointestinal 
quality of life on waist circumference. Regression results indicated that the model accounted for 
21.2% of the variance in the participants’ gastrointestinal quality of life and waist circumference 
(R2= .212, R2adj= .153, F (6, 80)= 3.59, p < .01). There were three statistically significant 
predictors of waist circumference including age, gender, and gastrointestinal quality of life after 
controlling for independent variables. Waist circumference was positively correlated with age; as 
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age increased, waist circumference increased. There was a statistically significant association 
between the male participants in this sample and an increased waist circumference. Waist 
circumference was negatively correlated with gastrointestinal quality of life; the larger the 
participants’ waist circumference the lower their gastrointestinal quality of life. 
Table 6 













(Constant) 102.164  7.848 .000 
Age .349 .289 2.800 .006** 
Gender -14.421 -.328 -3.151 .002** 
Ethnicity 2.850 .091 .876 .383 
Gastrointestinal 
Quality of Life 
-.234 -.274 -2.566 .012* 
Attempted Treatments -2.002 -.075 -.701 .485 
Duration of Symptoms 2.771 .094 .927 .357 




Out of the 98 participants that enrolled in the study, 86 participants completed the entire 
8-week study. Demographics of the 86 participants that completed the entire 8-week intervention 
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Table 7 
 
Post-Intervention Demographic Characteristics of Participants  
 
Variables N (%) Mean (SD) Range 























































Duration of Symptoms  


















Note. Participant numbers may vary from 86 as not all participants answered all questions.  
 
Two participants completed the pre-intervention survey, but withdrew prior to week 
one’s survey. One of the participants was a 39-year-old Caucasian female with the initial 
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complaint of diarrhea, reflux, and abdominal pain with and without food; this participant 
withdrew due to family illness. The other participant was a 39-year-old Caucasian female with 
initial complaints of constipation, bloating, and flatulence. The researcher reached out to this 
participant numerous times without a response; therefore the reason for withdrawal remains 
unknown.  
One participant withdrew by week 3. This participant was a 38-year-old Caucasian 
female with initial complaints of constipation, bloating, and flatulence. She withdrew due to 
unexpected travel out of the country without Internet excess.  
Three participants withdrew by week 4 of the intervention: (1) 33-year-old Caucasian 
female with initial complaints of bloating, reflux, flatulence, and abdominal pain with food, (2) 
38-year-old Caucasian female with initial complaints constipation, bloating, and belching, and 
(3) 59-year-old Caucasian female with initial complaints of constipation and bloating. The first 
participant withdrew due to increased bloating, the second withdrew due to increased 
constipation, and the third participant withdrew for unknown reasons.  
One participant withdrew by week five. This participant was a 35-year-old African 
American female with initial complaints of constipation, bloating, and reflux. The researcher 
reached out to her numerous times without a response.  
One participant withdrew by week six. This participant was a 42-year-old Caucasian 
female with complaints of constipation, bloating, reflux, and flatulence. This participant reported 
being too busy with her kids’ schedules.  
Two participants withdrew by week seven. One participant was a 55-year-old Caucasian 
female with initial complaints of constipation, bloating, and flatulence. The other participant was 
a 23-year-old Native American female with initial complaints of diarrhea, bloating, reflux, 
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flatulence, and abdominal pain with food. The researcher reached out to both of these 
participants numerous times without a response.  
Lastly, two participants did not complete the post-intervention survey. One of the 
participants was a 57-year-old African American female with initial complaints of constipation, 
bloating, reflux, flatulence, and abdominal pain with food. The other participant was a 31-year-
old Caucasian female with initial complaints of diarrhea, constipation, bloating, reflux, and 
abdominal pain with food. The researcher reached out to both of these participants without a 
response. 
Self-Reported Gastrointestinal Symptoms 
 
Each participant was asked to report his or her gastrointestinal symptoms at baseline, 
weekly, and after 8-weeks of probiotics, digestive enzymes, and glutamine. Each participant was 
asked to check which gastrointestinal symptom they experienced in the previous week. The 
covariate, gastrointestinal symptoms, was dichotomously coded 0/1 for “no” or “yes”. In order to 
do a more thorough comparison of symptoms, only those participants that completed the entire 
8-week study were included (n = 86). A paired samples t-test was conducted to evaluate whether 
there was statistically significant improvement in self-reported gastrointestinal symptoms after 
the 8-week intervention. The researcher verified the results with McNemar's test and found the 
same results. The only significant reduction in symptoms was abdominal pain related to food. 
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Table 8 









Symptoms N (%) N (%) t p value 
Diarrhea 28 (32.6) 26 (30.2) .705 .483 
Constipation 49 (57.0) 48 (55.8) .332 .741 
Bloating 77 (89.5) 74 (86.0) 1.000 .320 
Reflux 27 (31.4) 30 (34.9) -9.04 .369 
Belching 22 (25.6) 18 (20.9) 1.070 .288 
Excessive flatulence 53 (61.6) 45 (52.3) 1.583 .117 
Abdominal pain 
related to food 
46 (53.5) 34 (39.5) 2.787 .007** 
Abdominal pain 
unrelated to food 
16 (18.6) 15 (17.4) .257 .798 
Note: ** p < .01 
 
Post-Intervention Description of Research Instruments 
Prior to discussing the post-intervention research questions, table 9 provides a description 
of the research instruments and findings after eight weeks of probiotics digestive enzymes and 
glutamine.  
Table 9 
Description of Research Instruments (Post-Intervention) 























84.43 (12.74) 63-121 N/A   
Perceived  15.78 (5.89) 3-28 0-40 Normative 0.889 

































58.58 (8.73) 38-74 0-76  0.827 
 
Perceived Stress Scale. The Perceived Stress Scale was normally distributed in the post 
intervention data based on Fisher’s exact skewness statistic (.31) and kurtosis (.78) (Munro, 
2005). The normative scores for females was 13.7 and for males was 12.1 (Cohen & Williamson, 
1988). In this sample, 72.1% of the participants’ scored above 13 on the Perceived Stress 
Scale.  Out of the nine males in this sample, 3 scored above 12.5 on the Perceived Stress Scale 
(33.3%). Out of the seventy-three women that completed all of the necessary questions, 55 
scored above 14 on the Perceived Stress Scale (75.3%).  The Perceived Stress Scale had an 
acceptable Cronbach’s alpha of .89 (Di Lorio, 2005). 
Gastrointestinal Quality of Life Index. The Gastrointestinal Quality of Life Index was 
normally distributed in the post intervention data based on Fisher’s exact skewness statistic 
(1.94) and kurtosis (.65) (Munro, 2005). The normative value for the Gastrointestinal Quality of 
Life index is 125.8 (Eypasch, 1995). In this sample (n = 86), 70 (81.4%) of the participants 
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scored 124 or lower on the total Gastrointestinal Quality of Life Index. The total Gastrointestinal 
Quality of Life Index had an acceptable Cronbach’s alpha of .92 (Di Lorio, 2005). 
Weight and Waist Circumference. Weight was not normally distributed in the post-
intervention data based on Fisher’s exact skewness statistic (4.04) and kurtosis (.86) (Munro, 
2005; Tabachnick & Fidell, 2006). Analysis of the data indicated that there were no significant 
outliers. After completing a logarithm transformation, weight was normally distributed based on 
Fisher’s exact skewness statistic (2.58) and (.78). The resulting mean was 2.16 (SD = 0.94). 
Similarly to the pre-intervention data, there was a strong correlation between weight and 
waist circumference (r = .812, p < .01). Waist circumference was normally distributed in the 
post-intervention data based on Fisher’s exact skewness (2.76) and kurtosis (.32) (Munro, 2005). 
Due to the strong correlation and normality of data, only the participants’ waist circumference 
was reported when answering the clinical questions.  
Post-Intervention Clinical Research Questions 
The following research questions were conducted using the post-intervention data.  
Results for Research Question 7:  
Research Question 7: After 8-week treatment with probiotics, digestive enzymes, and 
glutamine, is there an association between perceived stress and gastrointestinal quality of life, 
weight, and waist circumference?  
Correlational analysis was used to evaluate the association between participants’ 
perceived stress, gastrointestinal quality of life, weight, and waist circumference after 8-week 
treatment with probiotics, digestive enzymes, and glutamine. Table 10 reports the Pearson 
correlations between all the main variables in this study after the 8-week intervention.  
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Table 10 
Pearson Correlations between the Major Variables (Post-Intervention) 
 1 2 3 4 5 6 7 8 9 
1. Age -         
2. Gender -.110 -        
3. Ethnicity .167 .090 -       
4. Duration of 
Symptoms 
.025 .051 -.185 -      
5. Attempted 
Treatments 
.041 .308** .037 .274* -     
6. Weight 
(Log)  
.131 -.330** .025 -.075 .021 -    
7. Waist 
Circumference  
.080 -.280* .043 -.141 .000 .812** -   
8. Perceive 
Stress Scale 
.040 .123 .076 -.021 .386** .115 .057 -  
9. 
Gastrointestinal 
Quality of Life  
-.030 -.208 -.166 .108 -.382** -.012 -.050 -.526* - 
Note: * p < .05, ** p < .01 
 Perceived Stress Scale. The association between perceived stress and gastrointestinal 
quality of life, weight, and waist circumference was tested with Pearson’s correlation coefficient. 
There was no statistically significant association between perceived stress and waist 
circumference (r = .057, p = .619). There was a statistically significant moderate correlation 
between perceived stress and gastrointestinal quality of life (r = -.526, p < .01). Participants with 
higher perceived stress reported the lower gastrointestinal quality of life.  
 Gastrointestinal Quality of Life. The association between gastrointestinal quality of life 
and perceived stress, weight, and waist circumference was tested with Pearson’s correlation 
coefficient. There was no statistically significant association between gastrointestinal quality of 
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life and waist circumference (r = -.05, p = .664). As previously stated, there was a statistically 
significant moderate correlation between gastrointestinal quality of life and perceived stress (r = 
-.526, p < .01). Therefore the higher perceived stress reported the lower gastrointestinal quality 
of life.  
 Waist Circumference. The association between waist circumference, perceived stress, 
and gastrointestinal quality of life was tested with Pearson’s correlation coefficient. There was 
no statistically significant association between waist circumference and gastrointestinal quality 
of life (r = -.05, p = .66) or perceived stress (r = .057, p = .62) in the post-intervention data.  
Results for Research Question 8:  
 Research Question 8: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) after 8-week treatment with 
probiotics, digestive enzymes, and glutamine what is the association of perceived stress on 
gastrointestinal quality of life?  
Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration of 
symptoms, number of attempted treatments, and perceived stress) were examined for 
multicollinearity. Although there were three statistically significant correlations, the strengths of 
the correlations remained low (r = 3.86, p < .01) indicating multicollinearity was not a problem 
(Munro, 2005).  
A simultaneous multiple linear regression was conducted to test the relationship between age, 
gender, ethnicity, duration of symptoms, number of attempted treatments, and perceived stress 
on gastrointestinal quality of life. Regression results indicated that the model accounted for 35% 
of the variance in the participants’ perceived stress and gastrointestinal quality of life (R2= .350, 
R2adj= .300, F (6, 78)= 7.005, p < .01). There were two statistically significant predictors of 
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gastrointestinal quality of life after controlling for independent variables included the number of 
attempted treatments and perceived stress. The higher level of perceived stress and the more 
treatments a participant had tried the lower the participants’ gastrointestinal quality of life. Table 
11 summarizes the multiple regression analysis.  
Table 11 













(Constant) 137.834  13.180 .000 
Age -.124 -.075 -.770 .443 
Gender -4.376 -.074 -.750 .456 
Ethnicity -4.214 -.096 -1.019 .311 
Duration of Symptoms 7.184 .172 1.727 .088 
Attempted Treatments -9.144 -.238 -2.212 .030* 
Perceived Stress -1.221 -.383 -3.769 .000** 
Note: * p < .05, ** p < .01 
Results for Research Question 9:  
 Research Question 9: Controlling for demographic variables (age, gender, ethnicity, 
duration of symptoms, and number of attempted treatments) after 8-week treatment with 
probiotics, digestive enzymes, and glutamine, what is the association between perceived stress 
on waist circumference?  
 In this study, there was no statistically significant correlation between perceived stress 
and waist circumference; therefore, a simultaneous multiple linear regression controlling for 
independent variables was not conducted.  
Results for Research Question 10 
 Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and 
number of attempted treatments) after 8-week treatment with probiotics, digestive enzymes, and 
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glutamine, what is the association between gastrointestinal quality of life on waist 
circumference?  
 In the study, there was no statistically significant correlation between gastrointestinal 
quality of life and waist circumference; therefore, a simultaneous multiple linear regression 
controlling for variables was not conducted.  
Results for Research Question 11  
Research Question 11: After 8-week treatment with probiotics, digestive enzymes, and 
glutamine, is there a statistically significant change in the gastrointestinal quality of life, weight, 
waist circumference, and perceived stress? 
 Paired samples t-test was used to evaluate whether there was statistically significant 
change in gastrointestinal quality of life, weight, waist circumference, and perceived stress after 
8 weeks of probiotics, digestive enzymes, and glutamine. A summary of the findings can be 
found in Table 12.  
Table 12 
Paired Samples T-Test after 8-Week Intervention 

















Quality of Life 
95.95 (15.94) 105.63 (18.43) -6.55 .000** 
Weight Log 2.17 (.097) 2.16 (.094) 2.55 .012* 
Waist 
Circumference 
84.21 (13.11) 84.18 (12.8) .039 .969 
Perceived Stress 16.37 (5.38) 15.78 (5.89) 1.302 .196 
Note: * p < .05, ** p < .01 
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Gastrointestinal Quality of Life. There was a significant difference in the gastrointestinal 
quality of life scores from the pre-intervention scores (M = 95.95, SD = 15.94) to post-
intervention scores (M = 105.63, SD = 18.43); t (85)= -6.56, p < .01. Therefore, participants had 
statistically significant improvements in their gastrointestinal quality of life after 8 weeks of 
probiotics, digestive enzymes, and glutamine.  
Weight. There was a significant difference in the participants’ weight from pre-intervention 
(M = 2.17, SD = .097) to post-intervention (M = 2.16, SD = .094); t (84) = 2.55, p = .012. 
Initially weight was not normally distributed; therefore the original weight data was examined 
with a Wilcoxon signed-rank test to verify the significance. A Wilcoxon signed-rank test showed 
that after 8 weeks of probiotics, digestive enzymes, and glutamine there was a statistically 
significant weight lost in participants (Z = -4.71, p < .01). The pre-intervention weight mean was 
152.18 pounds and the post-intervention weight was 149.07. As evident, with both the paired 
samples t-test and Wilcoxon signed-rank test, participants lost a statistically significant amount 
of weight over the 8-week intervention.  
Waist Circumference. There was no significant difference in waist circumference prior to 
the study (M = 84.21, SD = 13.11) and after the 8-week study (M = 84.18, SD = 12.8); t (70) = 
.39, p = .969. 
Perceived Stress. There was no significant change in perceived stress from baseline (M = 
16.37, SD = 5.38) to after the 8-week study (M =15.78, SD = 5.89); t (85) = 1.302, p = .196.  
Conclusion 
 This chapter presented the results of the research study. A total of 98 adults suffering 
from Functional Gastrointestinal Disorders were recruited from an Integrative Medicine office in 
Atlanta, Georgia. A total of 86 participants completed the entire 8-week intervention of 
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probiotics, digestive enzymes, and glutamine. Results indicated that there was a statistically 
significant association between minorities, higher levels of stress, and greater than 3 attempted 
treatments with lower gastrointestinal quality of life based on the Gastrointestinal Quality of Life 
Index.  
There was no statistically significant association between age, gender, or duration of 
symptoms and gastrointestinal quality of life. Men and increasing age were associated with 
larger waist circumferences. Results indicated that even though all of the self-reported 
gastrointestinal symptoms improved over the 8-week intervention (except for reflux), the only 
statistically significant improvement was seen in abdominal pain related to food.   
After the 8-week intervention, there was significant weight loss and increased 
gastrointestinal quality of life scores based on the Gastrointestinal Quality of Life Index. In 
conclusion, the results of this study support the use of probiotics, digestive enzymes, and 
glutamine to improve weight loss and gastrointestinal quality of life in individuals suffering from 










RESTORING DIGESTIVE HEALTH  88 
CHAPTER V 
Discussion  
 The purpose of this 8-week prospective cohort study was to determine whether 
probiotics, digestive enzymes, and glutamine are an effective regimen for improving 
gastrointestinal symptoms. Chapter V presents a discussion of the study’s results and concludes 
with the study’s strengths, limitations, implications for practice, and future research. This study 
is unique as it is the first to examine the combined benefits of probiotics, digestive enzymes, and 
glutamine for the management of Functional Gastrointestinal Disorder symptoms.  
This gastrointestinal protocol was designed to be an alternative method for restoring 
digestive health rather than managing symptoms in individuals suffering from Functional 
Gastrointestinal Disorders. The findings of this study examine the demographics associated with 
Functional Gastrointestinal Disorders and explore the hypothesis that there is a brain-gut 
connection. This study examined the brain-gut connection through the evaluation of the 
participants’ perceived stress based on the Perceived Stress Scale and gastrointestinal quality of 
life based on the Gastrointestinal Quality of Life Index. 
Demographics 
Age  
When examining the impact of age on Functional Gastrointestinal Disorders it does not 
appear to be an important demographic variable. In this study, there was no significant 
correlation between age and perceived stress or gastrointestinal quality of life. The only 
significant finding related to the participants’ age was that as their age increased, their waist 
circumference increased as well. Previous studies have found similar results. A longitudinal 
study conducted over 15 years in Australia found age to be the most important factor associated 
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with change in both weight and waist circumference (Arabshahi, Lahmann, Williams & van der 
Pols, 2014). Participants in this study continued to gain weight and waist circumference until age 
55 and 65 years old, respectively (Arabshahi et al., 2014).  
The age most affected by Functional Gastrointestinal Disorders remains inconclusive. 
This research study limited its sample to participants between the ages of 18-65 years old. The 
findings in this study resulted in a wide range of ages from 18-65 years old with a mean age of 
43.9 years old. The results of this study are congruent with other study findings. One study found 
that individuals younger than 50 years old were affected by irritable bowel syndrome more 
frequently (Scalera & Loguercio, 2012). Another large cohort study of 4,224 patients with 
Functional Gastrointestinal Disorders found the mean age to be 47.6 years old with an age range 
from 16-93 years old (Ford et al., 2014). This is similar to a large case-control study of 23,471 
diagnosed with Functional Gastrointestinal Disorders that reported a mean of 51.4 years old 
(Ford, Talley, et al., 2014). In Europe, a study was conducted that examined 199 patients with 
Functional Gastrointestinal Disorders and found the mean age to be 50 years old, with the ages 
ranging from 21-85 years old (Lahner et al., 2013).  
Although this study’s mean age results were similar to those found in other larger studies, 
it is important to remember that Functional Gastrointestinal Disorders do not discriminate based 
on age. Individuals can suffer from functional gastrointestinal symptoms from birth until death. 
This study limited the inclusion criteria to adult participants; however Functional 
Gastrointestinal Disorders affect children as well. Roughly 38% of school aged children 
complain of abdominal pain from functional origin on a weekly basis (Saps, Seshadri, 
Sztainberg, Schaffer, Marshall, & Lorenzo, 2009). It is estimated that anywhere from 25-66% of 
children with Functional Gastrointestinal Disorders continue to experience gastrointestinal 
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symptoms as adults (Campo et al., 2001). Therefore, patient outcomes can improve the earlier 
healthcare providers initiate a plan of care focusing on restoring digestive health.  
Gender  
Atlanta Center for Holistic and Integrative Medicine has more female than male patients. 
Since participants were recruited through the Center, it is not a surprise that the majority of the 
participants in this study were female (90.8%). Due to the majority of the participants being 
female, the analysis was run using females only to evaluate whether there were any differences 
in their self-reported gastrointestinal symptoms pre- and post- intervention, none were noted. 
However, literature worldwide has found that females suffer from Functional Gastrointestinal 
Disorders more frequently than males (Markert et al., 2014; Scalera & Loguercio, 2012; Myer et 
al., 2013; Sagawa et al., 2013; Ford et al., 2014; Porter et al., 2011; Lahner et al., 2013). In 
Western countries, it is estimated that females suffer from irritable bowel syndrome three times 
more frequently than males (Scalera & Loguercio, 2012). In Japan, a large Internet survey found 
a higher prevalence of functional dyspepsia and irritable bowel syndrome in females than males 
(Miwa, 2012). Porter et al (2011) found a seven-fold higher rate of functional constipation 
among females compared to males. 
In contrast, there was an epidemiological study conducted in Mexico that found all 
Functional Gastrointestinal Disorders to be equally prevalent across both genders except for 
irritable bowel syndrome and functional constipation, which was found to be more prevalent in 
women (López-Colombo et al., 2012). The exact etiology behind female predominance remains 
unclear. Further research is needed to explore the etiology behind this finding. Some possible 
theories include hormonal changes (especially in menstruating women) and differences in 
perceived stress since this study found a significant correlation between perceived stress and 
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gastrointestinal quality of life. However, since there were so few males in this study further 
research would need to be conducted to explore the impact gender has on Functional 
Gastrointestinal Disorders. 
Ethnicity  
Research examining the association between ethnicities and Functional Gastrointestinal 
Disorders remains limited. In this study sample, the majority of the participants were Caucasian 
(77.9%). This finding is even more diverse than other research studies conducted in the past. One 
study examined participants suffering from irritable bowel syndrome, diarrhea dominant (n = 
380) and functional diarrhea (n = 95) (Ford et al., 2013). The study reported a sample that was 
94.2% Caucasian in the irritable bowel syndrome group and 90.5% Caucasian in the functional 
diarrhea group (Ford et al., 2013). Another study conducted by Ford et al. (2014) found the 
majority of irritable bowel syndrome (87.4%) and chronic idiopathic constipation (88.9%) 
patients to be Caucasian. In contrast, Myer et al. (2013) found no statistically significant 
differences in ambulatory visits related to gastrointestinal symptoms between Caucasians and 
African Americans (Myer et al., 2013). 
Due to the majority of the participants being Caucasian, minorities were examined alone 
for improvements in self-reported gastrointestinal symptoms pre- and post-intervention. There 
were no statistically significant improvements in minorities’ self-reported gastrointestinal 
symptoms pre- and post-intervention; however, there was a statistically significant improvement 
in minorities gastrointestinal quality of life based on the gastrointestinal quality of life index. 
While both Caucasians and minorities had statistically significant improvements in their 
gastrointestinal quality of life, minorities had a larger change in their gastrointestinal quality of 
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mean scores. Figure 2 presents the pre- and post- Gastrointestinal Quality of Life scores in 
Caucasians versus minorities.  
 
Figure 2. Gastrointestinal Quality of Life Scores Pre- and Post- Intervention Based on Ethnicity 
Even with the low minority representation, the results found in this study were 
statistically significant. In this study, there was a significant association between minorities and 
lower gastrointestinal quality of life based on the Gastrointestinal Quality of Life Index. Even 
though there was an association between stress and gastrointestinal quality of life, the results of 
this study found no significant association between minorities and higher levels of perceived 
stress.  Therefore, further research is needed to determine the reason why minorities have lower 
gastrointestinal quality of life and the role ethnicity plays on Functional Gastrointestinal 
Disorders. 
Duration of Symptoms 
The symptoms associated with Functional Gastrointestinal Disorders are typically 
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individual has suffered from symptoms in the upper or lower gastrointestinal tract at least one 
time per week for 6 months without an organic cause (Lahner et al., 2013).   
In this study sample, the majority of the participants have suffered from functional 
gastrointestinal symptoms for longer than 10 years (32.7%). This validates the notion that those 
suffering from Functional Gastrointestinal Disorders have little to no improvement in their 
symptoms, leading to physical, mental, and emotional distress. There were no statistically 
significant differences found in the self-reported gastrointestinal symptoms pre- and post- 
intervention between participants that had symptoms for less than three years and those that had 
symptoms greater than three years. The purpose of this intervention is to offer an alternative 
method to shorten the length of time individuals with Functional Gastrointestinal Disorders have 
to suffer from the corresponding symptoms.   
Number of Attempted Treatments  
Due to the chronic nature of Functional Gastrointestinal Disorders, most individuals have 
attempted a number of therapies to improve their symptoms without success. Individuals 
suffering from functional gastrointestinal symptoms are desperate for relief. In this study, the 
majority of participants had tried 3-5 different treatments (33.7%) to alleviate their symptoms. In 
addition, the results of this study found a negative correlation between the number of attempted 
treatments and gastrointestinal quality of life scores. In other words, the more treatments a 
participant has tried the lower their gastrointestinal quality of life.  There were no statistically 
significant differences found in self-reported gastrointestinal symptoms pre- and post- 
intervention between participants that had tried less than three different treatments and those that 
had tried more than three different treatments.  
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Conventional or standard treatment for functional gastrointestinal disorders focuses 
primarily on symptom management with the use of laxatives, antidiarrheal, antispasmodics, or 
antidepressants. This symptom management approach has not been effective for managing 
Functional Gastrointestinal Disorders (Lahner et al., 2013). It is estimated that less than 50% of 
patients with irritable bowel syndrome are satisfied with their treatment plan (Aucoin, 2014). 
This is causing 21-51% of irritable bowel syndrome patients to seek complementary and 
alternative modalities (Aucoin, 2014). This gastrointestinal protocol of probiotics, digestive 
enzymes, and glutamine has the ability to restore digestive health and alleviate their symptoms.  
Self-Reported Gastrointestinal Symptoms 
 Although the gastrointestinal symptoms improved (except for reflux) after the 8-week 
intervention, the only statistically significant improvement was abdominal pain related to food. 
There are several theories to support the improvement in abdominal pain related to food. For 
instance, individuals that have a compromised digestive tract are more prone to having food 
allergies and food sensitivities.  Each of the three components in this gastrointestinal protocol 
(probiotics, digestive enzymes, and glutamine) plays a unique role in enhancing digestion and 
minimizing the negative effects of food allergies and sensitivities.  
 First of all, probiotics have been shown to function as a protective barrier, enhance 
immune response, and clear pathogens in the gastrointestinal tract (Ritchie & Romanuk, 2012). 
Marrs et al. (2013) conducted a systematic review to determine whether the human gut 
microbiota plays a role in food allergies. Out of five studies evaluating the gut microbiota, three 
of the publications reported significant findings to support the hypothesis that altered microbial 
exposure modulates risk of food allergies (Marrs et al., 2013). 
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Secondly, the amino acid glutamine is required for the normal production of 
immunoglobulin A in the intestines (Resnick, 2010). Improving immunoglobulin A in the 
mucosal lining can enhance the immune system and reduce the negative effects of food allergies 
and sensitivities. Glutamine also has been shown to have anti-inflammatory benefits in the 
intestinal tract (Ren et al., 2013). Therefore, glutamine can decrease the unpleasant side effects 
associated with gut inflammation after being exposed to food allergies or food sensitivities.  
Lastly, digestive enzymes have the ability to increase gastric digestion, which plays a role 
on food allergies (Untersmayr, 2015). The specific digestive enzyme used in this research study, 
Similase GFCF, contains enzymes that support the digestion of gluten and casein. These two 
proteins have been shown to cause a number of side effects. Gluten has been shown to have 
negative effects on individuals’ overall health including depression (Peters et al., 2014), foggy 
mind, bloating, and abdominal pain (Di Sabatino, 2015). Haq et al. (2014) found casein to cause 
a Th- mediated inflammatory response in the digestive tract of mice.  
In conclusion, although this study did not examine the participants’ diet, the 
implementation of this protocol can improve the way individuals respond to certain foods. 
Further research would be needed to examine the impact of various diets on Functional 
Gastrointestinal symptoms.  
Additional Comments 
 Each week participants had the opportunity to leave additional comments. There were 
several positive comments, as well as some negative feedback. It was interesting that some of the 
participants reported symptoms returning after missing just one day of supplements. Table 13 
presents some of the pertinent quotes found on the weekly survey.  
 
RESTORING DIGESTIVE HEALTH  96 
Table 13 
Additional Comments Found on Weekly Survey 
Week Pros Cons 
Week 1  “Constipation not quite as bad” 
 
“My bloating has started to decrease some 
and less nausea after my largest meal” 
 
“Happy to say that my bowel movements 
are very regular and good. Better than 
normal.    Also...been on vacation and 
eating a lot. Desserts! So not expecting to 
lose weight” 
 
 “Symptoms less intense and frequent” 
 
 “My nausea does not seem to be as bad 
after eating.  Think the powder is part of 
it.” 
 
 “I have noticed a difference with the 
probiotic as I have less bloating and gas 
than the previous week.” 
 
 “I will say that I have been going to the 
bathroom more frequently and my stool is 
softer, which I like.” 
 
 “My bowel movements have become more 
frequent.” 
 
 “I do feel like my constipation is a lot 
better” 
 
 “I feel I am having much less bloating, no 
diarrhea, more steady consistent BM's” 
“Feeling less bloaty. Still having some 
days where I have excessive gross 
gas...And dont feel fully ""regular"" 
yet...”  
 
“Extreme amount of gas” 
 
 “Not noticing any changes yet.  But 
hopeful” 
 
 “Feel extra gassy” 
 
 “I have more gas than usual.  I feel like 
I am having more normal stools.  I have 
begun an exercise program.” 
 
“I was very bloated and constipated for 
the first four days. It is better now but 
not great.” 
 
“I have experienced occasional nausea 
while on the supplements.” 
 
 “Increased gas and stomach gurgling!” 
 
Week 2 “My digestive system seems to have 
adjusted to the supplements!” 
 “Gas seems to be less and diarrhea was 
only once” 
 
 “Excited!  The first time in 30 years I have 
gone a week without taking laxatives of 
 “The excess gas is on a daily basis” 
 
 “Still experiencing slower transit of 
bowels each day” 
 
 “I believe my constipation has gotten 
worse since I started these supplements” 
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some kind.  I am 44 years old and had 
constipation all my life.  I am going regular 
every morning!! That is a blessing!!” 
 
 “Noticed I feel a burning in my adam 
Apple area and stomach when I missed the 
enzymes. I can see how how enzymes are 
important.” 
 “less bloating!” 
 
 “lol. It is my birthday week and I ate alot 
but my waist is shrinking.” 
 
 “I did not feel as good this weak. But I 
have had a lot of excess stress.” 
 
 “Experiencing extreme bloating when 
coffee is consumed, which was not 
present prior to this study. Significant 
decrease in bowel movements as well.” 
 
Week 3  “Feeling good!” 
 
 “Can see big difference in regularity. Less 
run to restroom/ diarrhea” 
 
 “Feeling better mentally.  Much less 
bloating and cravings!” 
 
 “Bowel movements are more regular” 
 
 “Reflux only 3 days last week.  Getting 
better.” 
 “Had a really bad flare up Sat through 
Tues....very very gassy, bloated, 
stomach pain, culminating in a lot of 
diarrhea Monday night. Kept me up all 
night.” 
 
 “Hormonal changes seems to change 
how digestive system works!” 
 
 “These supplements make me so 
constipated I am nauseous. I have to 
stop taking them this week. I believe it is 
the Glutamine, as I suspected I had 
similar problems when I tried it in the 
past.” 
 
 “Still no significant changes in bowels, 
gas, belching...still hopeful though!” 
 “I have not had bad stomach pains until 
this week.  I ate some ice cream and it 
killed my stomach.” 
 
 “Excessive gas this week.  Constipation 
is little better from last week” 
Week 4  “Bloating still present, but feels reduced.” 
 
“Starting to notice that my bowel 
movements are more complete, and I don't 
still feel constipated afterwards.” 
 
“I have felt really good this week.  I have 
had zero gluten or dairy.” 
 “I've occasionally felt nauseated after 
taking the digestive enzymes.” 
 
Week 5  “This program has consistently improved 
constipation symptoms.” 
“Really lots of gas” 
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 “The constipation was only for two days 
this week and no discomfort.   Much better 
than prior weeks.  I do see improvement” 
 
“I've noticed bloating and gurgling for a 
couple hours after the enzymes are 
taken.” 
 
Week 6  “Bloating discomfort is less!” 
 
 “Overall, my stomach has felt really good 
doing this study. I still have a little 
constipation.” 
 
“Feeling better, but still occasionally a lot 
of gas” 
 
 “See improvement in consistent bowel 
movements--even eating red meat and 
some dairy.  No problems.  I'm in week 2 
of a workout regimen so expect to see 
weight and inches lost due to this” 
 
 “While doing this study I have only had 
one really bad stomach pains. Usually I 
would have had several.” 
 
 “Really want to purchase these items after 
the test is over if possible.  Thanks” 
 “By week 6 I discovered that the 
supplements were making more 
uncomfortable than comfortable.  My 
constipation did not subside but I also 
become more crampy and bloated when 
taking the supplements.” 
 
 “Enjoying the process, yet still no 
significant changes in belching and 
constipation.  Thank you for doing this 
research though.” 
 
“I am extremely constipated.” 
 
Week 7  “Gas symptoms are consistent but the 
supplements aid in digestion (constipation 
has improved dramatically).  This is a more 
comfortable remedy than laxatives.” 
 
 “Bloating sensation is not as 
uncomfortable” 
 
 “I think the results would be more 
effective if I took the supplements for a 
longer period of time. I can feel the 
benefits, but I don’t think 8 weeks is 
enough time.” 
 
 “I experienced the above symptoms only 
on the 1 day that I missed my supplements 
for the day. Otherwise, I have been 95% 
symptom free, and have recommended the 
supplements to many people with similar 
“I'm surprised that I've struggled with 
constipation throughout this study.” 
 
 “These past 2 weeks I have been extremely 
constipated, gassy and belching. I haven't 
felt good at all.” 
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symptoms.” 
 
 “Feeling more joyful & energetic, Praise 
the Lord!!” 
 
 “Noticed a difference when I missed the 
glutamine.” 
 
 “Bloating was better this week” 
 
 “My stomach feels great! Still some 
constipation but overall I feel good.” 
 
 “Bloating was significantly less this week 
- not sure why” 
 
“the day I skipped I had the issues” 
 
“Thanks for the trial made a big difference 
in my life.” 
 
“This is the first week I've not had diarrhea 
- so happy!” 
 
Instruments 
Weight and Waist Circumference 
The results of this study reported a mean waist circumference of 84 cm.  The mean waist 
circumference in this study (84 cm) is below the criteria for the diagnosis of overweight or 
obesity (> 88 cm) based on the National Institute of Health (n.d) criteria. Due to the fact that 
participants did not report height, the researcher was unable to calculate participants body mass 
index to classify whether the participants were overweight or obese. However, based on waist 
circumference alone, the results of this study vary from the majority of the studies found in 
literature examining the relationship between Functional Gastrointestinal Disorders and weight 
and waist circumference.  
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Several studies found that individuals suffering from Functional Gastrointestinal 
Disorders were more likely to be overweight or obese (Lee et al., 2015, Yilmaz, 2013; Lahner et 
al., 2013). Lee et al (2005) reported an increased waist circumference associated with an 
increased risk of irritable bowel syndrome.  Yilmaz (2013) conducted a descriptive study in 
Turkey to evaluate effects of obesity on gastrointestinal quality of life. The results of this study 
found that obese patients suffered from gastrointestinal symptoms more frequently and had a 
decreased quality of life based on the Gastrointestinal Quality of Life Index (Yilmaz, 2013). 
Another study conducted on 199 European adults diagnosed with Functional Gastrointestinal 
Disorders found the average body mass index to be 39.2, which is considered class II obesity 
(Lahner et al., 2013). The findings in this study may differ from other studies due to the fact that 
the participants were recruited from a fee-for-service Integrative Medicine office in Atlanta 
where the majority of the patients are financially invested in their health and wellbeing.  
Although it is no surprise, this study found a significant association between weight and 
waist circumference. There was a positive correlation between weight and waist circumference; 
as participants’ weight increased, their waist circumference increased as well. Also, as suspected, 
the men in this study weighed more and had a larger waist circumference than females. These 
two statistically significant findings were anticipated.  
The researcher was specifically exploring the association between weight and waist 
circumference on gastrointestinal quality of life and perceived stress. The results of this study 
found no statistically significant correlation between waist circumference and gastrointestinal 
quality of life or perceived stress. However, over the 8-week course of probiotics, digestive 
enzymes, and glutamine there was a significant amount of weight loss. Surprisingly, based on 
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this study’s research findings, waist circumference was not a good indicator for the impact of 
Functional Gastrointestinal Disorders.  
Perceived Stress  
The results of this study validate the association between perceived stress and 
gastrointestinal quality of life. This study reported a negative correlation between perceived 
stress and gastrointestinal quality of life; as perceived stress increased, participants reported a 
lower level of gastrointestinal quality of life. These findings are similar to other research studies. 
Markert et al. (2014) conducted a study on 1857 participants, of that 62.78% met the criteria for 
at least one Functional Gastrointestinal Disorder. The results of this study found that those with 
higher levels of self-reported stress had worse gastrointestinal symptoms (Markert et al., 2014).  
 Another study was conducted on participants with irritable bowel syndrome (n = 105) to 
examine the association between social support and the severity of irritable bowel syndrome 
(Lackner et al., 2010). The Perceived Stress Scale was used to measure how the participants 
appraised their stress. The study found that perceived stress was a statistically significant 
predictor of pain severity (p < 0.05) (Lackner et al., 2010). Overall, this study validates that there 
is a brain-gut connection. However, further research is needed to explore whether stress or 
gastrointestinal symptoms is the initiating factor. In other words, is the association more brain-
gut or gut-brain?   
 
 
Gastrointestinal Quality of Life 
Although this study did not have a control (healthy) group, the total gastrointestinal 
quality of life scores were significantly lower than the normative results found in other studies; 
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confirming individuals suffering from Functional Gastrointestinal Disorders have lower 
gastrointestinal quality of life. Several other studies have confirmed the results found in this 
study, that Functional Gastrointestinal Disorders are associated with lower gastrointestinal 
quality of life (Sagawa et al., 2013; Miwa, 2012, Aro et al., 2011; Singh et al., 2012; Vu et al., 
2014).  
However after the 8-week intervention of probiotics, digestive enzymes, and glutamine 
there was a significant improvement in the participants’ self-reported gastrointestinal quality of 
life. In the post-intervention survey, the participants’ gastrointestinal quality of life scores were 
closer to the normative values seen in a healthy population, indicating significant improvements 
in their symptoms with the intervention (Eypasch, 1995). Therefore, this gastrointestinal protocol 
has the ability to improve individuals suffering from Functional Gastrointestinal Disorders 
overall gastrointestinal quality of life.  
Strengths of the Study 
 The researcher of this study has experience working with patients suffering from 
Functional Gastrointestinal Disorders. In practice, this protocol has been shown to improve 
patients’ gastrointestinal symptoms.  However, this is the first research study to examine and 
validate the combined benefits of probiotics, digestive enzymes, and glutamine on Functional 
Gastrointestinal Disorders. The procedures involved in this study were safe to take with 
additional medications or supplements. The primary purpose was to examine how the protocol 
would work in the average patient as they conducted their normal life. One of the strengths of 
this study was the large sample size (n = 98). The attrition rate was low (12.2%) with 86 
completing the entire 8-week intervention.  Another strength of the study was that all of the 
instruments had strong internal consistency based on Cronbach’s alpha of greater than 0.7.  
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Limitations of the Study 
 There were several limitations in this study. One of the largest limitations was that there 
was not a control group to compare findings. Also, participants self-reported their own weight 
and waist circumference increasing risk of human error. Since participants used their own scales 
at home, there was no standardized calibration of the scales to ensure accuracy. All results were 
self-reported and not validated through medical examination. However, the way a participant 
perceives their gastrointestinal symptoms is essential to how they perceive their overall health. 
The fewer symptoms patients experience the fewer medical office visits they will require; which 
will ultimately decrease the costs associated with Functional gastrointestinal Disorders.  
The participants did not complete the full Rome III Criteria survey to diagnosis 
participants with specific Functional Gastrointestinal Disorders, such as irritable bowel 
syndrome, functional constipation, functional dyspepsia, etc. Further research would be needed 
to examine whether specific Functional Gastrointestinal Disorders respond better to the 
intervention of probiotics, digestive enzymes, and glutamine. 
Another limitation to the study was that the population examined was not diverse with the 
majority of the participants being Caucasian and female; this is partly due to the fact that 
participants were recruited from Atlanta Center for Holistic and Integrative Medicine where the 
primary demographic is Caucasian and female. This study did not control for a number of 
variables including dietary changes, alcohol intake, or prescribed medications that may alter the 
findings. A prospective cohort study is a good way to measure outcomes over time, however 
with this study design causality cannot be inferred.  
Implications for Practice 
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 Several implications for healthcare practice can be derived from the findings of this 
study. One of the significant findings, that is relevant to practice, is the higher level of perceived 
stress participants report the lower their gastrointestinal quality of life. It is essential to 
implement measures that encourage healthcare providers to address the whole patient including 
their perceived level of stress. 
 Secondly, this intervention of probiotics, digestive enzymes, and glutamine resulted in 
improvements in participants’ quality of life. Being that this protocol has been shown to be safe 
and effective, implementing this protocol into practice has the ability to improve Functional 
Gastrointestinal Disorder patients’ quality of life and decrease the costs associated with frequent 
medical office visits related to gastrointestinal symptoms.  
 If feasible, healthcare providers should explore potential food allergies and sensitivities 
that may be playing a key role in individuals’ abdominal pain related to food. As evident in this 
research study, the gastrointestinal protocol significantly improved the participants’ abdominal 
pain related to food. However, it would be beneficial to have an understanding of which foods 
may be aggravating their symptoms.  
 Being that these three supplements are naturally derived from food and do not go through 
the CYP450 system, there are less adverse effects and drug-drug interactions. Conventionally, 
proton pump inhibitors are one of the most widely used drugs for reflux. These medications can 
have detrimental effects on individuals overall health including malabsorption of B12, iron, 
magnesium and decreased bone density (Ito & Jensen, 2010). Implementing the more natural 
alternative of probiotics, digestive enzymes, and glutamine has been shown to be a safe and 
effective treatment for managing Functional Gastrointestinal Disorder symptoms.  
Implications for Theory Building 
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 Betty Neuman’s Healthcare System model was the foundation for this research study. 
This model stresses the fact that each client’s system is unique with no two patients identical. On 
a daily basis, the human body is exposed to known and unknown stressors that can disrupt the 
body’s stability (Neuman, 1989). Based on the findings in this study, Betty Neuman’s Healthcare 
System model could be expanded to specifically relate to individuals suffering from Functional 
Gastrointestinal Disorders. It is clear that the gastrointestinal tract could be affected by a number 
of stressors including food sensitivities, food allergies, emotional stress, or bacteria. The 
digestive tract would remain the core with three surrounding lines of defense. Each line of 
defense would represent a component of the gastrointestinal protocol including probiotics, 
digestive enzymes, and glutamine. The primary purpose of the lines of defense is to strengthen 
the digestive tract to prevent dysfunction from both internal and external stressors.  
Future Research 
Based on the results of this study, there are several areas that need additional research. 
The participants in this study were not diverse. Further research is needed to evaluate the role 
gender and ethnicity play on Functional Gastrointestinal Disorders. Possible theories for the 
female predominance include hormonal variations and perceived stress; however, the exact 
etiology behind the increased female prevalence remains vague and inconclusive.  
Although minorities were shown to have lower gastrointestinal quality of life, the cause 
for this correlation remains unknown. Initially, it was thought that perceived stress might be 
contributing to lower gastrointestinal quality of life in minorities. However, the statistical 
analysis did not support this hypothesis. Therefore, future research is needed to explain the 
correlation between minorities and lower gastrointestinal quality of life. 
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Also, this study examined the combined benefit of probiotics, digestive enzymes, and 
glutamine; further research would be needed to determine which of the three of these 
supplements makes the largest impact on gastrointestinal symptoms. Lastly, further research is 
needed to determine whether these supplements actually restore digestive health or whether they 
just temporarily improve the symptoms. Therefore, future follow up with the participants is 
necessary to determine whether the symptoms returned after completing the 8-week intervention.  
Dissemination  
The research findings were disseminated through a podium presentation at Georgia 
Nursing Leadership Coalition’s Doctoral Symposium in November 2015. The findings of this 
study will be shared with each of the three supplement companies including Metagenics, 
Orthomolecular, and Integrative Therapeutics. The author plans to apply for publication with the 
Functional Medicine Journal, the American Journal of Gastroenterology, the Journal for Nurse 
Practitioners, or Journal of Family Medicine and Primary Care.  
Conclusion 
 This study adds to the body of literature that explores effective therapies for addressing 
Functional Gastrointestinal Disorders. This population often has little to no improvement in their 
symptoms with conventional therapies focusing on symptom management. Functional 
Gastrointestinal Disorders have a negative effect on patients overall health. The intervention of 
probiotics, digestive enzymes, and glutamine has been shown to be safe, natural, and effective 
for reducing gastrointestinal symptoms. While this study is the first to collectively examine the 
benefits of probiotics, digestive enzymes, and glutamine, the science behind each component is 
evident. After the 8-week intervention, there were significant improvements in weight loss and 
gastrointestinal quality of life. Therefore, this protocol has the power to transform patient’s 
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Appendix B  
Recruiting Flyer 
Suffering with Digestive Issues? 
 
Do you have bloating, constipation, diarrhea, flatulence, reflux, or abdominal pain? 
We may have the solution for you! 
 
Atlanta Center for Holistic and Integrative Medicine is starting a research study to help restore 
your digestive health THIS summer and we NEED you! 
 
This research study will be conducted over 8 weeks. As a participant of the study, you will 
receive all supplements FREE OF CHARGE. Over the 8 weeks, you will be responsible for 
taking a pre and post survey, responding to a brief weekly email, and taking the daily 
supplements as recommended.   
 
Please see the inclusion and exclusion criteria below to see if you may qualify. If you are 
interested please email kristin.corbin@bobcats.gcsu.edu for more information.  
 
Inclusion Criteria: 
 Male or female aged 18-65 years old 
 Current digestive symptoms  
 Physical exam within the past 12 months 
 Proficient in English 
 Have internet access for weekly emails 
 Own a scale and measuring tape in centimeter 
 Be willing to sign an informed consent  
Exclusion Criteria:   
 Younger than 18 years old or older than 65 years old 
 Pregnant or nursing  
 Diagnosed with an organic disease, such as Crohn’s disease, ulcerative colitis, or 
gastrointestinal tumors 
 You will be excluded from this study if you respond “yes” to any of the following 
questions: 
o In the past 3 months, have you noticed blood in your stools? 
o In the past 3 months, have you noticed black stools, unrelated to iron 
supplements? 
o In the past 3 months, how often have you vomited blood? 
o Have you been told by your doctor that you are anemic (if female, not due to your 
menstrual cycle)? 
o In the past 3 months, have you lost 10 lbs of weight unintentionally? 
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o If over the age of 50, have you had a recent major change in bowel movements? 
o In the past 3 months, have you had persistent or worsening hoarseness of the 
voice? 
o In the past 3 months, have you had persistent or worsening neck or throat pain?  
o In the past 3 months, have you had chest pain on exertion, or chest pain related to 
heart problems? 
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Appendix C 
Informed Consent 
Informed Consent Form 
  
Restoring Digestive Health 
With Probiotics, Digestive Enzymes, and Glutamine 
 
PURPOSE OF RESEARCH 
 
You are invited to participate in a research study on restoring digestive health.  The primary goal 
of this research study is to determine whether a well-established protocol used at Atlanta Center 
for Holistic and Integrative Medicine is effective at restoring digestive health. This protocol 
utilizes probiotics, digestive enzymes, and glutamine.   
 
You were selected as a possible participant in this study because you are currently suffering from 
gastrointestinal symptoms. This research study is looking for 100 participants with functional 
gastrointestinal disorders including reflux, constipation, diarrhea, nausea, abdominal pain, 
bloating, and irritable bowel syndrome.  
 
VOLUNTARY PARTICIPATION  
 
Your participation in this study is entirely voluntary.  You are free to terminate your participation 
in this study at any point without reason. If you decide to terminate your participation, please 
notify Kristin Corbin at kristin.corbin@bobcats.gcsu.edu. 
 
INCLUSION AND EXCLUSION CRITERIA 
 
By signing this informed consent you are agreeing to the sample criteria. Please read through the 
inclusion and exclusion criteria entirely.  
 
Inclusion Criteria: 
 Male or female aged 18-65 years old 
 Current digestive symptoms  
 Physical exam within the past 12 months 
 Proficient in English 
 Have internet access for weekly emails 
 Own a scale and measuring tape in centimeter 
 Be willing to sign an informed consent  
Exclusion Criteria:   
 Younger than 18 years old or older than 65 years old 
 Pregnant or nursing  
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 Diagnosed with an organic disease, such as Crohn’s disease, ulcerative colitis, or 
gastrointestinal tumors 
 Please read and answer the questions below thoroughly: 
o In the past 3 months, have you noticed blood in your stools?  
_____  Yes      _____  No 
o In the past 3 months, have you noticed black stools, unrelated to iron 
supplements? 
_____  Yes      _____  No 
o In the past 3 months, how often have you vomited blood? 
_____  Yes      _____  No 
o Have you been told by your doctor that you are anemic (if female, not due to your 
menstrual cycle)? 
_____  Yes      _____  No 
o In the past 3 months, have you lost 10 lbs of weight unintentionally? 
_____  Yes      _____  No 
o If over the age of 50, have you had a recent major change in bowel movements? 
_____  Yes      _____  No 
o In the past 3 months, have you had persistent or worsening hoarseness of the 
voice? 
_____  Yes      _____  No 
o In the past 3 months, have you had persistent or worsening neck or throat pain?  
_____  Yes      _____  No 
o In the past 3 months, have you had chest pain on exertion, or chest pain related to 
heart problems? 
_____  Yes      _____  No 
o In the past 3 months, have you had difficulty swallowing? 
_____  Yes      _____  No 
 
DURATION OF STUDY INVOLVEMENT  
 




If you choose to participate, you will be asked to complete a pre and post intervention 
questionnaire and measurements including weight and waist circumference. The initial and post 
questionnaire is estimated to take 20-30 minutes to complete. Over the course of the 8 weeks, 
you will receive a brief weekly email with four questions to answer including (1) how many 
supplements were missed in the previous week, (2) what is your current weight, (3) what is your 
current waist circumference, and (4) any additional comments you would like to share. The 
weekly email is estimated to take 5-10 minutes to complete.  
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The intervention for this study consists of probiotics, digestive enzymes, and glutamine. It is 
important that these supplements are taken daily. The probiotics and glutamine are taken by 
mouth in the morning and the digestive enzymes can be taken with your largest meal of the day.  
 
The brands most commonly used at Atlanta Center for Holistic and Integrative Medicine will be 
used for the study. You will receive the probiotics, digestive enzymes, and glutamine for free. 
Orthomolecular, Integrative Therapeutics, and Metagenics donated the supplements for the 
purpose of this study. Kristin Corbin does not have any financial benefits from using these 
products, nor is she invested in the companies in anyway.  
 
Risks: 
The risks associated with each of these supplements are minimal. The only associated side effects 
found is mild cramping, abdominal pain, or bloating. 
 
IF YOU FEEL DISCOMFORT AT ANY TIME, NOTIFY KRISTIN CORBIN AT 
KRISTIN.CORBIN@BOBCATS .GCSU.EDU AND DISCONTINUE THE 
SUPPLEMENTS.  
 
The results of the study will remain anonymous and will not be linked with your name. The 
results are to be used for research purposes only.  
 
 
PARTICIPANT RESPONSIBILITIES           
 
As a participant, your responsibilities include:  
 Follow the instructions outlined in the introduction video 
 Complete the pre and post questionnaire 
 Complete the weekly email questionnaire 
 Take the study supplements as instructed  
 Tell the researcher about any side effects you may experience 
 Tell the researcher if you believe you might be pregnant 
 Keep the study supplement in a safe and cool place- out of the direct sun 
 Ask questions as needed 
 Tell the researcher if you would like to terminate your participation  
 
 
WITHDRAWAL FROM STUDY 
 
If you first agree to participate and then change your mind, you are free to withdraw your 
consent and discontinue your participation at any time. If you decide to withdraw your consent to 
participate in this study, you should notify Kristin Corbin at Kristin.corbin@bobcats.gcsu.edu 
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POTENTIAL BENEFITS                              
 
The researcher cannot guarantee or promise that you will receive any benefits from this study. 
However, this well-established protocol has been found beneficial at Atlanta Center for Holistic 




You should not feel obligated to agree to participate.  Your questions should be answered clearly 




There are no costs associated with this research study. All necessary supplements will be given 




The purpose of this research study is to obtain data or information on the safety and effectiveness 
of probiotics, digestive enzymes, and glutamine; the results may be disseminated in medical 
journals, healthcare conferences, and poster presentations. Your identity and/or your personal 
health information will not be disclosed. Prior to beginning the study you will receive a unique 
identification number that you will be prompted to input on each questionnaire rather than your 




________________________________             ______________ 
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Appendix D 
Participants Study Checklist  
Items to Complete Estimated Date Completed Date 
Sign Informed Consent June 15, 2015  
Pick Up Supplements  By June 20, 2015  
Watch the Introduction Video  By June 25, 2015  
Watch the “How to Measure 
Weight and Waist 
Circumference” Video 
 
By June 25, 2015  
Complete the pre-intervention 
questionnaires 
 
By June 28, 2015  
Start the supplements July 1, 2015  
Week 1 Email July 8, 2015  
Week 2 Email  July 15, 2015  
Week 3 Email July 22, 2015  
Week 4 Email July 29, 2015  
Week 5 Email August 5, 2015  
Week 6 Email August 12, 2015  
Week 7 Email August 19, 2015  
Week 8: Post-intervention 
questionnaire 
August 26, 2015  
 
 
